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Abstract 
Oxidative stress may play a role in the pathogenesis of Autism Spectrum Disorders (ASD). We 
evaluated a high number of peripheral oxidative stress parameter, erythrocyte and lymphocyte 
membrane functional features,  morphology and membrane lipid composition of erythrocyte.  The 
study was conducted in two successive steps (First Study and Second Study), involving a total of 29 
autistic children (Au) aged 5 to 12 years, and 28 gender and age-matched typically developing 
children (TD), some of which have took part in both studies (4 Au and 4 TD) [First study results has 
been published in Plos One (Ghezzo A et al. 2013)].   
Erythrocyte TBARS (MDA), Peroxiredoxin II, Protein Carbonyl Groups and urinary HEL and 
Isoprostane levels were elevated in AU, thus confirming the occurrence of an imbalance of the 
redox status of Au;  other oxidative stress markers or associated parameters (urinary 8-oxo-dG, 
plasma Total antioxidant capacity and plasma carbonyl groups, erythrocyte SOD and catalase 
activities) were unchanged, whilst peroxiredoxin I showed a trend of elevated levels in red blood 
cells of Au children.  
A very significant reduction of both erythrocyte and lymphocyte Na+, K+-ATPase activity (NKA) 
(P<0,0001), a reduction of erythrocyte membrane fluidity, a reduction of Phospatydylserine 
exposition on erythrocyte membranes,  an alteration in erythrocyte fatty acid membrane profile 
(increase in MUFA and in ω6/ω3 ratio due to decrease in EPA and DHA) and a reduction of 
cholesterol content of erythrocyte membrane were found in Au compared to TD, without change 
in erythrocyte membrane sialic acid content and in lymphocyte membrane fluidity. Some Au 
clinical features appear to be correlated with these findings; in particular, hyperactivity score 
appears to be related with some parameters of the lipidomic profile and membrane fluidity, and 
ADOS and CARS score are inversely related to peroxiredoxin II levels.  
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Oxidative stress and erythrocyte structural and functional alterations may play a role in the 
pathogenesis of ASD and could be potentially utilized as peripheral biomarkers of ASD.  
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Introduction 
Autism  Spectrum Disorders (ASD) are neurodevelopmental disorders characterized by a marked 
decrease in social interaction and communication. Anatomical, ultrastructural and/or functional 
alterations have been identified in brain areas such as Broca's area, the brainstem, cerebellum, the 
limbic system, the parietal lobe and the corpus callosum. Complex immune system abnormalities 
were also found. 
Diagnosis of ASD is only based on clinical features, and at present there are no validated 
biomarkers for diagnostic and/or screening purposes (Momeni N et al. 2012). The causes of autism 
are still unknown. The nature of the disorder, in fact, and the complex relationships involving 
mind-brain, does not allow to refere to the sequential model etiopathogenesis, commonly used in 
medical disciplines: etiology -> pathology -> pathogenesis -> symptomatology (Rapin, 2004). It 
should also be considered that autism, which is defined exclusively in terms of behavior, appears 
as the final event of various pathological conditions of different etiology (Baird et al., 2003) and 
therefore presents significantly heterogeneous clinical pictures (Moreno et al., 1982). 
Genetic susceptibility, immunologic alterations, toxicological and environmental factors have been 
proposed to play an etio-pathogenic role in ASD (Theoharides TC et al. 2009). Recent studies 
showed an impairment of mirror neurons system (Cattaneo L et al. 2007), that maps visual 
descriptions of actions done by others onto the observer’s motor representations of the same 
actions.  No curative pharmacological treatment are available. It has been suggested that oxidative 
stress may play a role in the etio-pathogenesis of ASD [James SJ et al. 2004; Chauan A and chauan 
V, 2006; James SJ et al. 2006).  
PhD in Science of…
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Development
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Fig. 1: Autism encopasses  the four 
components of the PhD School in 
Pharmacological, Toxicological, 
Developmental ad Human 
Movement Science 
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1. Oxidative stress 
Oxidative stress is defined as the disruption of the normal intracellular balance between reactive 
oxygen species (ROS), produced either during aerobic metabolism or as a consequence of 
pathologic processes and antioxidant defence mechanisms (Sies H, 1985; Rokutan K er al., 1989).  
Oxidative stress, in turn, induces the secretion of numerous vasoactive and pro-inflammatory 
molecules [Frossi  B et al. 2003] leading to neuroinflammation [Theoharides TC et al. 2009].  
Thanks to an antioxidant system, in physiological conditions the organism is able to defend itself 
from the presence of oxidizing agents; the antioxidant system includes enzymes and molecules 
which counterbalance the production of reactive oxygen or nitrogen species (ROS and NOS 
respectively). If the generation of oxidants exceeds the antioxidant capacities of the cell, it is 
established a condition called oxidative stress (H Sies, 1997). 
ROS are molecules characterized by a remarkable chemical reactivity: they are in fact constituted 
by an atom or a molecule that has at least one unpaired electron in the orbital more external. 
They are then able to bind other radicals or subtract an electron to other neighboring molecules to 
balance their electromagnetic charge. This mechanism gives rise to new unstable molecules, 
triggering a chain reaction that, if not stopped in time, ends up damaging the cell structures. In 
fact, ROS are able to oxidize the hydrocarbon chains of unsaturated fatty acids, the amino acid 
residues of the protein and the nitrogenous bases of nucleic acids. These changes alter the 
functionality of these biomolecules thus compromising the biological functions. ROS are 
neutralized by anti-oxidants used by the body to protect itself from the damaging effects of free 
radicals. The anti-oxidant enzymes are a wide range of enzymes that transform ROS into harmless 
substances. In this category are included Superoxide Dismutase (SOD) and Catalase. The SOD is the 
first defense against ROS and in particular transforms the superoxide radical in hydrogen peroxide. 
The latter is eliminated by the action of catalase which converts it into water and oxygen. There 
are other enzymes such as glutathione reductase and glutathione transferase involved in GSH 
synthesis. Besides the antioxidant enzymes, there are anti-oxidants devoid of catalytic activity that 
are defined secondary antioxidants. One of the most important antioxidants is glutathione (GSH); 
GSH is the most powerful and important of antioxidants produced by the body. It is a tripeptide 
consisting of cysteine, glycine and glutamate. Glutathione is necessary to maintain a reducing 
environment capable of preserving nuclear proteins and protect DNA from oxidizing agents. At the 
8 
 
level of red blood cells GSH plays an important role, protecting these cells from oxidative 
phenomena that would cause hemolysis. Thanks to its structure GSH is able to give electrons to 
the oxidized molecules by oxidizing in turn. Glutathione, once oxidized, can become extremely 
toxic to the cell, which is, however, able to control the balance between reduced glutathione and 
oxidized glutathione. In fact, the oxidized GSH (GSSG) is reduced to GSH by the action of the 
enzyme glutathione reductase (GSR) containing the NADPH. The enzyme transfers the electrons 
transferred from NADPH to oxidized glutathione (GSSG) turning it into reduced glutathione (GSH). 
In addition to GSH, important secondary antioxidants are vitamin A, fat soluble vitamin present in 
foods of animal origin, vitamin C, water-soluble vitamin, and vitamin E, which is considered the 
most potent lipophilic antioxidant; part of the secondary antioxidants are also carotenoids, plant 
pigments lipid present in foods of plant origin, polyphenols, especially abundant in fruits and 
vegetables and the catechins contained in cocoa, wine and tea; also copper and zinc are 
antioxidants of mineral origin and are contained in legumes and in the meat (Sies H, 1993). 
Oxidative stress can be detected by studying a panel of different markers [Frustaci A et al. 2012], 
some of which, such as DNA, proteins and polyunsaturated fatty acid (PUFA) residues, are 
pathognomonic of oxidative damage of biomolecules. 
2. Autism Spectrum Disorders (ASD) 
Autism is a behavioral syndrome caused by a developmental disorder biologically determined, 
with onset in the first three years of life. The areas mainly concerned are those relating to social 
interaction, the ability to communicate ideas and feelings and the ability to establish relationships 
with others (Baird et al., 2003; Berney, 2000; Szatmari, 2003 a and b). 
Autistic Disorder is characterized by qualitative impairment of reciprocal social interaction, verbal 
and nonverbal communication, behavior and imaginative activity. A characteristic feature of the 
syndrome is the presence of stereotyped behaviors, in particular gestural stereotypes.  
The Cognitive impairment is frequent (70-90% of patients have an IQ below 70, a 40% is within the 
range of moderate to severe mcognitive impairment). Epilepsy, especially of partial type, shows a 
higher incidence than the general population. 
Autism was first described in 1943 by psychiatrist Leo Kanner, who noted that some children had a 
pathological behavior different than children with mental retardation or schizophrenia. In 
particular, the children described by Kanner showed an inability to relate to other people. He 
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called this syndrome "Early Infantile Autism" (Kanner 1943). The disease is characterized by a 
variety of symptoms and is quite difficult to provide a comprhensive clinical definition, so that it 
comes to autism spectrum disorders (or Autistic Spectrum Disorders), just to indicate a number of 
diseases or syndromes with defined behavioural features. Autism symptoms and severity vary 
from one individual to another. Autistic people have, first of all, deficit and atypia of social 
interaction: they tend to isolate themselves from the outside world and refuse contact with 
others. Often have abnormal responses to sounds, touch and other sensory stimuli. The lack of 
communication is nonverbal (gaze, facial expressions, gestures) and verbal (language), which in 
some cases can lead to a total failure of expression or use of an incomprehensible language. They 
showed also repetitive and stereotyped behavior such as the use of certain sequences of 
movements, specific rituals or habits. Some subjects showed a marked resistance to change that 
can occur if the subject is removed from its environment or if the environment is changed. Finally, 
they may show outbursts, sudden laughter or crying without any reason (Filipek PA et al., 1999). 
The causes of this disease are still unknown; one hyopethesis is that environmental and genetic 
factors may contribute to its development. Several studies suggest an important role of oxidative 
stress in pathogenesis of autism (A Chauhan et al., 2006; Rossignol DA et al., 2012). In particular, in 
recent years, various studies have shown alterations in some markers of oxidative stress and 
antioxidant molecules (Goldani AA et al., 2014). The disease is diagnosed around or before the 3 
years of a child's life. The diagnosis of autism is based primarily on clinical parameters, by using 
specific International Classification Scales; the diagnosis is based on the presence of a number of 
behavioral features identified after the observation of the subject. To date there are still no 
molecular markers able to diagnose this disease. Studies are directed to search for specific 
markers able to make an early diagnosis in order to promptly intervene with specific habilitation-
rehabilitation approaches. 
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2.1 .Clinical aspects of ASD 
Fig 2: Diagnosis of
autism Spectrum
Disorder
Is increasing
worldwide.
Enormous social 
and health impact.
 
Diagnosis of autism Spectrum Disorder is increasing worldwide (Fig 2). The most recent 
epidemiological studies by the Centers for Disease Control and Prevention (CDC) of Atlanta,  
reported that in USA one child in 68 is affected by ASD. As for Italy was highlighted that the 
prevalence of at least 5 cases out of 10 000 for children attending the elementary school rises 
above 7 out of 10 000 (CDC, 2006). More recent data have shown an increase in cases of autism in 
Italy. This increase is thought to be due by the improvement of diagnosis and by a greater 
awareness of autism by operators. Autism affects mainly males at a rate four times higher than 
the female. 
In the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and in 'International 
Classification of Mental and Behavioral Disorders (ICD-10), autism is part of Pervasive 
Developmental Disorders (Pervasive Developmental Disorders, PDD), that is characterized by 
severe and pervasive impairment in social, behavioral and communication. The diagnosis of ASD is 
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usually made between 2 and 3 years of age. The diagnosis is based on parameters using behavioral 
rating scales as the ADOS (Autism Diagnostic Observation Schedule), the ADI-R (Autism Diagnostic 
Interview-Revised (Lord et al., 1994, 2000) and CARS (Childhood Autism Rating Scale) (Schopler et 
al., 1988). It is very important to make an early diagnosis in the early years of life, to allow  a 
specific intervention in a period of life when the brain has a certain plasticity. The role of parents 
in the identification of the first symptoms (such as anomalies in the behaviour) appears to be 
crucial (De James A. et al., 1998).  
Autistic symptoms vary from one individual to another and they display various levels of severity. 
Common Clinical characteristics are: 
• Difficulties in social interaction: the subject shows an apparent lack of interest to other people, 
or to what is happening around him; prefer not to be touched or embraced; shows a high 
tendency to isolation and closure and difficult to participate in group games. It is not unusual that 
children with autism are initially diagnosed as deaf because they do not show any reaction when 
called by name (Filipek PA et al., 1999). 
• Difficulty in verbal communication: the individual repeats the same words or phrases 
repeatedly; answers questions by repeating the question (echolalia); uses language incorrectly 
(phonological and morpho-symptatic errors); has difficulty in communicating needs and desires; 
does not understand simple instructions, requests and questions; interprets what he is told in a 
very literal way (not able to understand the irony and sarcasm) (Amato CAH et al., 2010). 
• Difficulty level of nonverbal communication: avoid eye contact, use facial expressions that are 
not consistent with what they are saying and react unusually to some visual and auditory stimuli 
(Amato CAH et al., 2010; Jones W et al., 2008). 
• Presence of rigid and stereotyped behaviors: autistic children present rigid behavior (for 
example: insist on doing the same road to go to school); have difficulty in adapting to any change 
in the day ( e.g. to eat at a different time than usual) or of the environment (e.g.moving furniture); 
they show an unusual attachment to objects or particular games; they align obsessively objects; 
repeat the same actions or movements over and over again. The autistic person may explode in 
fits of tears and laughter, they can become self-defeating, hyperactive and aggressive toward 
others or toward objects.  
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People with autism often have abnormal responses to sounds, touch and other sensory stimuli. 
Many show reduced sensitivity to pain, but they can also be extraordinarily sensitive to other 
sensations. This altered sensitivity may contribute to behavioral symptoms such as resistance to 
be embraced. 
 
2.2 Neurological abnormalities 
Neuropathological feature of ASD are characterized by changes concerning the development of 
atypical certain brain structures and the levels of connection between the different areas as well 
as dysfunction of neurotransmitters in the central nervous system and immunological 
abnormalities. 
Neuroimaging studies showed several features including an increased density of nerve cells at the 
level of certain brain structures such as the cerebellum, hippocampus and amygdala; the latter, is 
a brain structure, part of the limbic system, that plays a role in the emotional integration, and 
instinctive behavior of the individual (Vivanti G. 2007; Amaral DG et al., 2008). Furthermore MRI 
studies have shown that the volume of the amygdala and hippocampus is increased in children 
with autism compared to controls. The cause of these changes, however, is still unknown 
(Schumann CM et al., 2004). 
Studies have been conducted that showed abnormalities in the connections between neurons in 
specific brain areas such as the auditory cortex (Roberts TP et al., 2010; Roberts TP et al., 2011), 
and changes in the volume and symmetry of the two cerebral hemispheres (Wallace GL et al., 
2010; Kosaka H et al., 2010). 
At the cellular level have been highlighted anomalies in the functioning of nerve synapses, mainly 
those γ-aminobutyric acid-mediated (GABA). Moreover, there were defects in the synthesis and 
release of the neurotransmitter serotonin (5HT), involved in the modulation of mood and behavior 
of the individual: a deficiency of serotonin in the frontal lobes can be correlated with impulsivity 
and obsessive-compulsive symptoms typical of autism (Lambiase M, 2004). Functions such as 
perception and attention, which are regulated by the neurotransmitter dopamine system, are 
compromised in individuals with autism. 
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Recently, a defect of neural pruning has been shown in pyramidal cells of the layer V in the 
temporal cortex; this defect is associated with a deficiency of macroautophagy, in turn due to 
excessive activation of the kinase mTOR (Tang G et al., 2014). 
Alterations of the immune system and neuroinflammatory processes were showed int the cerebral 
cortex and cerebellum (Vargas DL et al., 2005). 
In children with ASD was highlighted the presence of certain gastrointestinal disorders such as 
abdominal pain, constipation, chronic diarrhea, vomiting and gastroesophageal reflux (JF White, 
2003). The association between DSA and gastrointestinal symptoms remains unclear. The high 
presence of gastrointestinal disorders in individuals with autism is associated with a selective 
behavior towards the food (Ibrahim SH et al., 2009; Smith RA et al ., 2009). 
2.3 Etiopathogenesis of Autism Spectrum Disorders 
Autism is a complex disorder characterized by a heterogeneous phenotype; it is believed that 
autism may be a multifactorial disorder in which genetic and environmental factors are 
intertwined each other. 
2.3.1 Environmental Factors 
The exposure to a large number of complications in the pre- and postnatal period may increase 
the risk of autism; among the factors that were associated with the risk of developing the disease, 
there are, for example, complications due to the umbilical cord, size and weight for gestational 
age, medications taken during pregnancy and neonatal anemia (Gardener H et al., 2010 ). 
It is known that exposure to environmental toxicants, such as mercury, lead, arsenic and toluene, 
can lead to neurological disorders, such as psychiatric disorders, schizophrenia and depression 
(Rossignol DA and Frye RE, 2011). In recent years, several studies have shown a possible link 
between ASD and exposure to environmental toxins such as heavy metals, pesticides and 
chemicals. These substances can damage nerve cells, causing the increase of oxidative stress, 
reduced glutathione and the impairment of cellular signaling. A study carried out in 2014 
confirmed the association between ASD and exposure to toxic substances: the results of this 
research suggest that, at least in a subset of children, there are complex interactions between 
some environmental toxicants and genetic factors and that they may act synergistically (or in 
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parallel) during the critical periods of neurological development, to increase the likelihood of 
developing autism (Rossignol DA et al., 2014). 
In recent years, vaccines containing mercury (Thimerosal as a preservative) have been the subject 
of study and controversy. In 1998, the British doctor Andrew Wakefield suggested a possible 
association between vaccines and autism spectrum disorders. Wakefield was referring in particular 
to the MMR triple vaccine against measles, mumps and rubella (Godlee F. et al., 2011). The 
hypothesis advanced by Wakefield was soon disproved. To date, no significant results were 
obtained on a possible link between MMR vaccine and autism (Hertz-Picciotto I et al., 2009; 
Holmes AS et al., 2003). 
2.3.2 Genetic factors 
The hypothesis that genetic factors may be implicated in the pathology of autism was confirmed 
primarily through studies of monozygotic and dizygotic twins (Bailey A et al., 1995). The data 
obtained showed in monozygotic twins a high concordance rate for autism. From these studies it 
was assumed that genes could play a primary role in the manifestation of the disorder. The 
identification of the genetic determinants underlying autism is a complex issue: the pathogenesis 
is probably heterogeneous, not attributable to the action of a single gene, but several genes may 
contribute together to the development of autism.  
To date, the identification of genes involved in the disease is still very complicated; most of the 
changes highlighted was indeed found in sporadic cases. Some research groups have used an 
approach based on the analysis of the entire genome to identify susceptibility loci (Lamb J et al. 
2002). The strategy is to analyze the human genome through genetic studies of linkage, to study 
the inheritance of DNA markers in families with at least two individuals with autism. This 
experimental approach allows to identify which regions of the genome are "more similar" 
between the pairs of affected siblings in each family: in fact, if a region of a chromosome contains 
a gene involved in autism, this region will be inherited, with some frequency, by both affected 
siblings. The comparison of the results obtained by different research groups showed certain 
chromosomal regions in which is probably located a susceptibility locus for autism. The most 
significant results concerning chromosomes 2q and 7q (IMGSAC, 2001). Particularly interesting is a 
chromosomal region identified on chromosome 7q22-q23, where are located several genes 
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involved in disorders of speech and language, wich are very important clinical signs in autistic 
patients.  
Promsing studies are directed towards the search for "candidate genes", ie genes involved in brain 
development, neurotransmitters or neuromodulators located in chromosomal regions with 
evidence of linkage. The genes involved in the metabolism of serotonin or other neurotransmitters 
have been the subject of study by several research groups (Maestrini E et al., 1999). The 
identification of genes involved in autistic disorder will be of great importance for the 
understanding of the neuropathological mechanisms underlying the disorder, the development of 
more accurate methods of diagnosis and the identification of specific drug targets.  
2.3.3. Metabolic alterations 
Molecular and behavioral evidence indicates an association between sex hormones and steroids in 
autism. In some subgroups of individuals with autism was found an altered metabolism of steroid 
hormones, particularly testosterone (Ruta L et al., 2011) and cholesterol (Aneja A et al., 2008). This 
finding may explain the high rate of autism in males than females. Furthermore, conditions related 
to altered levels of testosterone, such as polycystic ovary syndrome, are reported in women with 
autism. Cholesterol is essential for the production of neuroactive steroids and for a normal 
embryonic and fetal development. It also modulates the oxytocin receptor and the serotonin 
receptor. A deficit of cholesterol can disrupt these biological mechanisms and, therefore, 
contribute to the ASD. 
Recently, it has been suggested that oxytocin may play a role in the manifestation of the social 
deficits of autism. Oxytocin is a hormone considered a major regulator of social behavior in 
humans. Clinical studies have shown that treatment with oxytocin is able to change some aspects 
of behaviour as the ability to participate in a game where interaction with others is required 
(Andari E et al., 2010). Many studies have tried to associate the presence of autistic disorders with 
genetic disorders involving the gene of oxytocin and/or its receptor. Mutations in the gene 
encoding for the oxytocin receptor, as well as epigenetic modifications leadind to an alteration in 
the phenotypic level, has been shown (Gregory SG et al, 2010). 
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2.4 Therapy 
Currently there is no cure for autism. The therapies used are chosen according to the specific 
symptoms of each subject and include mainly a psycho-educational program (which aims to 
improve cognition and behavior of the child) and, to a lesser extent, a drug treatment. Such 
interventions do not cure autism, but it can often lead to an improvement in the quality of life of 
the child. The educational and behavioral treatments are designed to help the child to develop 
social skills and language. This type of therapy should begin as soon as possible: an early 
intervention has a good chance to positively influence the brain development. Drug therapy is 
aimed primarily at reducing some of the symptoms associated with autism such as poor attention 
and obsessive-compulsive behaviors. In particular, drugs that regulate the serotonin, as inhibitors 
of serotonin reuptake, reduce repetitive and aggressive behaviors (McDougle CJ, et al., 1996; 
Gordon, 1993). Other medications inhibit impulse transmission in dopaminergic neurons, reducing 
some behavioral manifestations (Anderson et al., 1989). Finally, the use of a nutraceutical 
approach may be useful in autistic subjects, as it could lead to an improvement in antioxidant 
capacity with consequent reduction of oxidative stress (Abdulrahman SA, 2013). 
 
2.5 Autism and oxidative stress  
Oxidative stress has been suggested to underlie several mental disorders, including schizophrenia 
and bipolar disorder [Andreazza AC et al. 2008; Ng F et al., 2008; Tsaluchidu S et al. 2008], and 
neurodegenerative pathologies such as Alzheimer disease [Porter MM et al., 1995; Sultana R et al. 
2010]. In autism there is growing evidence of increased oxidative stress. Glutathione redox status 
has been found to be decreased in autistic patients, also in the post-mortem analysis of Autistic 
brain tissues (Rose S et al. 2012). Low levels of exogenous antioxidants vitamin C, vitamin E, 
vitamin A in plasma, zinc and selenium in erythrocytes, has been shown (SJ James et al. 2004). The 
imbalance of membrane fatty acid composition and PUFA loss can affect ion channels and 
receptors [Murphy MG 1990]. In particular, Ca2+ channel deficiency was found in Au [Krey JF and 
Dolmetsch RE 2007], but never correlated to membrane parameters. A reduced level of energy 
metabolism was also found in autistic subjects; reduced synthesis of ATP (Chugani et al., 1999) and 
high levels of lactate and pyruvate (Coleman and Blass, 1985), elements that may suggest an 
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altered mitochondrial metabolism in autism (Graf et al., 2000; Filipek et al., 2003). Oxidative stress 
is one of the major causes of reduced mitochondrial metabolism (Packer, 1984). In addition to the 
high levels of oxidative stress, neuroinflammation (activation of microglia and elevated levels of 
proinflammatory cytokines) may play a role in the development of histopathological changes in 
Autism (Vargas et al. 2005). 
Tables 1A and 1B show a summary of main published results on oxidative stress and on fatty acid 
composition of the erythrocyte membrane in Autism, respectively. 
 
 
 
 
Tab 1A: Summary of main published results on oxidative stress involvement in autism. 
1) Anti oxidant enzymes  
Author year Plasma, urine or cells  Results 
Yorbik, Sayal, Akay, Akbiyik, 
Sohmen 
2002 Plasma per GPX e SOD1, RBC 
per GPX 
Plasma GPX, plasma SOD1, RBC GPX 
Sogut, Zoroglu, Ozyurt, 
Yilmaz, etc 
2003 Plasma, RBC per NO Plasma GSH, SOD1=, TBARS=, GPX, RBC NO 
Zoroglu, Armutcu, Ozen 
Gurel, etc 
2003 RBC TBARS, SOD1, XO, CAT, TBARS= 
Chauhan Chauhan, Brown, 
Cohen 
2004 Plasma MDA, lipids peroxidates, transferrine, 
cerulopasmine 
Ranjbar A, Rashedi V, Rezaei 
M. 
2014 Urine total antioxidant concentration (TAC), catalase 
activity (CAT) and total thiol molecules (TTM) 
Ngounou Wetie AG, Wormwood 
K, et al. 
2014 Serum apolipoproteins ApoA1 and ApoA4 and 
paraoxanase/arylesterase 1 
Kovač J, Macedoni Lukšič M et al. 2014 DNA Rare single nucleotide polymorphisms in the 
regulatory regions of the superoxide dismutase genes 
Zhang QB, Gao SJ, Zhao HX 2015 Serum thioredoxin 
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2) Lipids and oxidative stress markers 
Author year Plasma, urine or cells  Results 
Vancassel, Durand, etc 2001 Plasma PUFA 
Chauhan Chauhan, Brown, 
Cohen 
2004 Plasma Lipids peroxidates  
Ming, Stein, Brimacombe, etc 2005 Urine isoprostane, 8-OHdG 
Bu, Ashwood, Harvey, etc 2006 RBC Eicosanoic Acid , erucic acido  
Tostes MH, Teixeira HC, Gattaz 
WF, Brandão MA, Raposo NR. 
2012 Plasma VIP, IFN-γ and NO ,  NT-3  
Ming X, Stein TP, Barnes V, 
Rhodes N, Guo L. 
2012 Urine  glycine, serine, threonine, alanine, histidine, taurine 
carnosine 
El-Ansary A, Al-Ayadhi L. 2012 Plasma PGE2, leukotrienes and isoprostanes 
Pecorelli A, Leoncini S, De Felice 
C, et al. 
2013 Plasma and erythrocyte non-protein-bound iron (NPBI), and 4-
hydroxynonenal protein adducts (4-HNE PAs)  
Napoli E, Wong S, Giulivi C. 2013 MitochondrialDNA(peripheral 
blood monocytic cells) 
mtDNA deletions 
Gorrindo P, Lane CJ, 2013 Plasma  F2t-Isoprostanes 
Frye RE, Delatorre R 2013 Plasma 3-chlorotyrosine (3CT,  measure of chronic immune 
activation), GSH 
Gu F, Chauhan V et al. 2013 Brain (frontal cortex) defects in complexes I and III (sites of mitochondrial 
free radical generation) and complex V (adenosine 
triphosphate synthase), Piruvate Dehydrogenase 
Kuwabara H, Yamasue H et al. 2013 Plasma arginine and taurine  
5-oxoproline and lactic acid 
Ciccoli et al. 2013 RBC RBCs altered morphology  
F2-isoprostanes and 4-hydroxynonenal protein 
adducts.  
oxidative damage of β-actin protein  
Napoli E, Wong S, Hertz-
Picciotto I, Giulivi C 
2014 Granulocytes defects in oxidative phosphorylation, immune 
response, and antioxidant defense 
3) transmethylation/transsulfuration metabolism 
Author year Plasma, urine or cells  Results 
Jill James, Cutler, etc 2004 Plasma Metionina, SAM, omocisteina, cistationina, 
GSH, SAH, adenosina, GSSG 
Jill James, Melnick, etc 2006 Plasma Differenze nella frequenza allelica di geni correlati  
Muratore CR, Hodgson NW et al. 2013 Brain methionine synthase mRNA 
Hodgson NW, Waly MI, 2014 Serum  glutathione  
homocysteine and S-adenosylhomocysteine  
4) nutraceutical and antioxidant approaches 
Authors year Supplement Results 
Richrdson, Montgomery 2005 ω3, ω6 Improvement 
Amminger, Berger, etc 2006 ω3 Improvement 
Frye RE, Rossignol DA. 
(review) 
 
2014 l-carnitine and a multivitamin 
containing B vitamins, 
Carnosine, 
 antioxidants, vitamin E, and co-
enzyme Q10  
ubiquinol, 
folinic acid, methylcobalamin 
with and without folinic  
vitamin C and N-acetyl-l-cysteine 
tetrahydrobiopterin. 
Improvement 
Singh K, Connors SL, et al. 
 
2014 Sulforaphane Improvement 
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Tab 1B: Summary of main published results on fatty acid composition of the erythrocyte membrane 
(from Ghezzo et al., 2013, modified) 
 fatty acid composition of 
erythrocyte membrane 
Patients 
Highly unsaturated fatty acids 
(HUFA)  
decreased 1 ASD patient (Bell JG et al., 2000) 
Stearic acid (18:0) 
Arachidic acid (24:0) 
Total SFA  
Oleic acid (18:1 n-9) 
Nervonic acid (24:1) 
Total MUFA  
Linoleic acid (18:2 n-6) 
Docosapentaenoic acid (22:5 n-
6) 
ARA (20:4 n-6) 
DPA (22:5 n-3) 
Total ω3 
Arachidonic acid (ARA):EPA 
ratio  
(20:4 n-6/20:5n-3) 
increased 
increased 
increased 
decreased 
increased  
decreased 
increased 
increased 
decreased 
decreased 
decreased 
increased 
18 Au children with developmental regression (Bell JG et al, 
2004) 
Stearic acid (18:0)  
Arachidic acid 24:0  
Nervonic acid (24:1) 
Docosapentaenoic acid (22:5 n-
6) 
DPA (22:5 n-3) 
Total ω3 
Arachidonic acid (ARA):EPA 
ratio  
(20:4 n-6/20:5 n-3) 
increased 
increased 
increased 
increased 
decreased 
decreased 
increased 
11 children with Classical autism or Asperger (Bell JG et al, 
2004) 
eicosenoic acid (20:1n9) 
erucic acid (22:1n9)  
total MUFA 
increased 
increased 
increased  
20 Au children with developmental regression (mean age 3.5 
years) (Bu B et al., 2006) 
α-Linolenic acid (18:3 n-3) 
Arachidonic acid (ARA):EPA 
ratio  
(20:4 n-6/20:5 n-3)  
decreased 
increased  
49 Au children (mean age 7.5 years) (Bell JG et al. 2010) 
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3. Research project 
3.1 Objective 
The aim of our study was to evaluate  
a) a broad spectrum of oxidative stress markers in Au children, in order to assess the possible 
imbalance of their redox status, taking into account the correlation between peripheral and 
central nervous system markers of oxidative stress [Skoumalova A et al. 2012];  
b) structural, functional and morphological features of erythrocytes, in particular membrane fatty 
acids composition. In fact there is a growing evidence of a strong correlation between erythrocyte 
fatty acid membrane profile and preservation/degeneration of brain functions in aging and in 
neurodegenerative diseases [Kim M, et al. 2010], [Tan ZS et al. 2012]. Moreover erythrocyte 
membrane ω6/ω3 balance has been related to inflammation markers [Calder PC 2011].  
c) a possible correlation between biochemical and cinical features; 
d) therapeutic suggestions (based on biochemical alterations) aimed at reducing some of the 
symptoms; the examined parameters are also potentially useful peripheral biomarkers of ASD. 
To our best knowledge, this is the first study which evaluates, at the same time, such wide range 
of different but strongly related biological biomarkers, in a group of ASD children that underwent 
a rigorous clinical characterization. 
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3.2 Materials and Methods 
Table 2: research groups involved in the study 
FIRST STUDY 
Subjects Laboratory Evalualtions 
Au: 21 
TD: 20 
Marini M, University of Bologna Urinary HEL,  isoprostane, 8-oxo-dG 
Marini M. University of Bologna Plasma carbonyl groups 
Marini M. University of Bologna Erythrocyte SOD and catalase activities 
Ferreri C. CNR Bologna Erytrocyte membrane Lipidomics 
Mazzanti L.  Università of Ancona Erythrocyte Na+, K+-ATPase activity (NKA) 
Mazzanti L. University of Ancona TBARS, sialic acid 
Mazzanti L. University of Ancona Erythrocyte membrane fluidity 
Manfredini S. Unversity of Ferrara ORAC 
 
SECOND STUDY 
Sujects Laboratory Evaluations 
Au: 12 
TD: 12 
 Marini M. University of Bologna Cholesterol erythrocyte membrane 
 Marini M. University of Bologna Erythrocyte membrane sphingolipids  
 Marini M. + Manara (Rizzoli, Unibo) Annexin V (phosphatidylserine) 
 Marini M. University of Bologna Hydrophilic heads of  phospholipids (erytrocyte 
membranes) 
Ferreri C. CNR Bologna Erytrocyte membrane Lipidomics 
Marini M. + Prof.ssa Farruggia (Unibo) Glutathionylation in red blood cells and white blood 
cells 
Marini  M. University of Bologna Glutathionylation Subunits of  Na K ATPase 
(erythrocyte membranes)  
Marini M.University of Bologna Evaluation of Subunits of  Na K ATPase (erythrocyte 
membranes)  
Marini M. University of Bologna Evaluation of mRNA Subunits of  Na K ATPase 
(erythrocyte membranes) 
Mazzanti L. University o Ancona Lymphocyte Na+, K+-ATPase activity (NKA) 
Mazzanti L. University of Ancona Lymphocyte membrane fluidity 
De Franceschi L. University of Verona Peroxiredoxin  I 
De Franceschi L. University of Verona Peroxiredoxin  II 
De Franceschi L. University Verona Catalase (erythrocyte) 
Marini M. University of Bologna Erythrocyte carbonyl groups 
  
  
  
Au 29 
TD:28 
Fedrizzi G. (Istituto Zooprofilattico Bologna) Evaluatin of a broad spectrum of metals (plasma and 
urine) 
Gabbianelli R. (Camerio), Dimingues V.(Porto) Permethrin metabolites (urine) 
Naila Rabbani (Warwick University) Protein glycation (plasma and urine) 
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 3.2.1 Ethics Statement 
The present study was conducted according to the guidelines laid down in the Declaration of 
Helsinki and all procedures involving human patients were approved by Local Ethical Committee 
First Study: Azienda USL Bologna, CE 10020- n.30, 06/04/2010 prot 45424/10-03. Second Study:   
Prot. N.642/CE Bologna, 01 July 2013 and Prot. N.1198/CE Bologna, 23 December 2013. Written 
consent was obtained from all parents and also from children through pictures and simplified 
information. 
3.2.2 Subject  
The study was performed in two steps.  
First Study. A first group of 48 children was approached as part of the first case–control study. Of 
these, 25 had a diagnosis of Autism (Au) and 23 were classified as Typically Developing (TD) 
children. Of these, 21 were recruited for inclusion in the study from the autism group (4 Female 
and 17 Male), and 20 in the TD group (6 F and 14 M). Reasons for rejection included: taking fish oil 
supplements (two subjects in the Au group), taking vitamins and/or other substance known to 
have antioxidant properties (two subjects in Au group and 3 subjects in TD group). 
Au group mean age was 6.8 years (SD = 2.23 years, median = 6 years, range 5–12 years); in TD 
group mean age was 7.6 years (SD = 1.96 years, median = 7 years, range 5–12 years). Both the 
non-parametric comparison of the average age in the two groups and the comparison by gender 
(chi-square test), were not significant, confirming the comparability between cases and controls. 
Second Study. A second group of 24 children was approached as part of the second case–control 
study. Of these, 12 had a diagnosis of Autism  (9 M and 3 F) and 12 were age and gender matched 
Typically Developing children. Au group mean age was 7.8 years (SD= 1.9 years, median = 7.4 
years, range 6-10 years ). 
All the patients were admitted to Child Neuropsychiatric Unit of the Maggiore Hospital of Bologna 
(Neurological Sciences Institute IRCCS-Bologna), for assessment by a comprehensive diagnostic- 
neurological workup and regular follow-ups. None of the autistic patients had active epilepsy at 
the time of blood and urine sampling. One patient experienced a first and (at the moment of 
writing this paper) single benign rolandic seizure six months after the blood and urine collection 
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(this patient was the only one with a normal intellectual level). Any medical and neurological 
comorbidity was excluded by electroencephalography (recorded during awake and sleep), cerebral 
magnetic resonance imaging, standard clinical and neurological examination, neurometabolic and 
genetic investigations (including 550 band karyotype, and molecular assay for Fragile X and 
MECP2). No infective or inflammatory disease was detected at the time of blood collection. No 
subject underwent any surgery intervention in the four months prior to blood and urine collection. 
Autism diagnosis was made according to the Diagnostic and Statistical Manual of Mental Disorders 
IV (DSM IV TR [American Psychiatric Association (2000)]) criteria, Autism Diagnostic Observation 
Schedule (ADOS) [Lord C et al. 1999] and Childhood Autism Rating Scale (CARS) [Schopler E. Et al. 
1988] by two clinicians (a child neuro-psychiatrist and a child psychologist) experienced in the field 
of autism. Developmental and cognitive levels were assessed by Psychoeducational Profile-3 (PEP-
3) [Schopler E. Et al. 2005] and Leiter International Performance Scale–Revised (Leiter-R) [Roid 
GM, Miller LJ (1997)]. Parents were questioned regarding the age of onset of early autistic signs. 
Demographic and clinical features of Au groups are summarized in Table 3 and Table 4. Control 
group children were healthy TD children, recruited in the local community, with no sign of 
cognitive, learning and psychiatric involvement, as clinically and anamnestically determined by 
three experienced clinicians. All TD were attending mainstream school and had not been 
subjected to stressful events. Dietary habits were assessed by a Food Questionnaire. All patients 
and controls were on a typical Mediterranean diet. 
24 
 
Tab 3: Demographic and clinical features of the autistic children group (First Study)  
(from Ghezzo A. et al. 2013, modified) 
 
No. 
 
 
 
 
 
Gender 
 
 
 
 
Age (months) 
 
 
 
Age of onset (months) Cognitive/ 
developmental 
impairment 
 
 
ADOS 
score 
 
 
 
CARS 
score 
 
 
 
CARS 
activity level 
item score 
 
CARS stereotypes 
(body use) 
item score 
 
1 
M 66 ≤12 Moderate 18 40.5 2.5 3.5 
2 M 74 ≤12 Severe 21 42 2.5 2.5 
3 M 64 ≤12 Moderate 16 35 2.5 2 
4 M 103 13-18 Moderate 19 44.5 3 3 
5 M 61 ≤12 Severe 21 46 3.5 4 
6 M 71 13-18 Severe 22 41 2 3 
7 M 142 ≤12 Severe 22 44.5 2.5 3 
8 M 131 13-18 Severe 16 38 3 3 
9 M 66 13-18 Moderate 22 40.5 3 3 
10 F 66 13-18 Borderline IQ 15 41.5 2.5 2 
11 M 74 13-18 Severe 22 42.5 3 2.5 
12 F 66 13-18 Severe 22 43.5 3.5 3.5 
13 M 66 13-18 Mild 14 34 2 2 
14 M 89 19-24 Mild 19 40 3 3 
15 M 102 13-18 Mild 22 36.5 2 2.5 
16 F 110 25-30 Moderate 15 47.5 3.5 3 
17 M 79 13-18 Moderate 19 37 2.5 3 
18 M 144 13-18 Severe 20 39 3 3.5 
19 M 80 ≤12 Normal IQ 19 36.5 2.5 2 
20 M 79 ≤12 Severe 21 40.5 2.5 3 
21 F 65 ≤12 Mild 17 31.5 2 2 
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Tab 4: Demographic and clinical features of the autistic children group (Second Study) 
 
No Gender Age 
(Months) 
Cognitive/ 
developmental  
impairment 
 
Ados 
Score  
Cars 
total 
score 
Cars 
activity 
level 
item 
score  
Cars 
stereotypies 
(body use) 
item score  
CARS verbal 
language 
(expressive) 
item score 
CARS non 
verbal 
language 
item score 
 
CARS 
total number 
of items 
whose score 
was ≥3 
1 m 68 Severe 20 41,5 2,5 3 3 3 11 
2 m 94 Severe 21 46 3,5 4 4 4 11 
3 f 68 Normal IQ 20 43,5 2,5 3 3,5 3 10 
4 m 93 Severe 20 48,5 3 4 3,5 3 12 
5 m 82 Moderate 19 42 3 3 3 3 9 
6 m 115 Severe 19 39,5 3 3 3 3 7 
7 m 74 Severe 19 41 2,5 3 3 3 9 
8 m 99 Moderate 16 35 2,5 2 3 3 3 
9 m 85 Moderate 22 41 2,5 2 3 3 7 
10 f 74 Severe 17 38 2 2,5 3 3 7 
11 f 124 Normal IQ 21 33,5 2 2 2,5 2,5 4 
12 m 129 Normal IQ 19 39 2 2,50 3 3 7 
 
 
3.2.3 Biochemical Evaluations 
Blood samples, obtained from Au and TD children, were collected in Na2-EDTA (~9 mL) and 
heparin (~5 mL) vacutainers. Some hematological parameters were carried out by routine 
laboratory techniques. One ml Na2-EDTA whole blood was set apart for lipidomics evaluation. The 
remaining blood was centrifuged (10 min. at 1000×g) in order to separate the plasma, which was 
frozen at −80°C in 1 mL eppendorf sterile tubes. Na2-EDTA and heparinised plasma was used for a 
radical absorbance capacity (ORAC) test and protein carbonyl evaluation, respectively. After 
diluting (1:1) the cell suspension with sterile Phosphate Buffered Saline (PBS), mononuclear white 
blood cells were separated from red cells by Ficoll (Histopaque 1077, Sigma, St.Louis, MO, USA) 
density gradient centrifugation. Cells were lysed in 1 mL Trizol® Reagent (Invitrogen, Milan, Italy) 
and stored at −80°C for other evaluations. In order to remove all Ficoll residue red blood cells were 
washed three times with PBS. Erythrocytes in Na2-EDTA were stored at 4°C and then used for the 
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evaluation of Na+/K+-ATPase activity (NKA) and cell membrane fluidity. Heparinised red blood 
cells (RBC) were used for the evaluation of superoxide dismutase (SOD) and catalase activity. In 
particular, for SOD activity measurement, heparinised RBC were lysed in 4 volumes of ice-cold 
water and then stored at −80°C. The remaining heparinised RBC were diluted 30-fold in PBS and 
subsequently lysed in 10 mM potassium phosphate buffer pH 7.2. Lysates were stored at −80°C 
and subsequently were used for catalase activity evaluation. Spot urine samples (10 mL) from Au 
and TD were collected. Proteinuria and creatinine determinations were carried out by laboratory 
techniques. The remaining urine was centrifuged at 1200 g for 10 min in order to remove insoluble 
materials. Five mL of clear urine were aliquoted and stored at −80°C for hexanoyl-lysine adduct 
(HEL) and 8-isoprostane evaluations. The remaining urine was filtered with 0,45 µm filter, 
supplemented with 0.05% sodium azide and stored at −80°C for 8-hydroxy-2′-deoxyguanosine (8-
oxo-dG) analysis. 
Urinary 8-isoprostane. 
Urinary 8-isoprostane (also known as 8-epi-PGF2α, 8-iso-PGF2α or 15-isoprostane F2t) was 
determined by the use of a competitive ELISA kit (Oxford Biomedical Research Inc., Oxford, MI, 
USA). As suggested by the manufacturer, urine samples are diluted 1:5 with a buffer provided in 
the kit. The 15- isoprostane F2t in the samples competes with 15-isoprostane F2t conjugated to 
horseradish peroxidase (HRP) for binding to a polyclonal antibody specific for 15-isoprostane F2t 
coated on the microplate. A substrate was added and the absorbance was measured at 450 nm in 
a microplate reader. The 15-isoprostane F2t concentration was expressed in ng per milligram of 
creatinine. 
Urinary hexanoyl-lysine adduct. 
Hexanoyl-lysine adduct (HEL) concentration was measured by a competitive ELISA kit (JaICA, 
Fukuroi, Shizuoka, Japan) in unfiltered urine of autistic and control children. According to the 
manufacturer's instructions, urine samples were diluted five times with PBS. Some urine samples 
containing proteins were treated with 14 mg/mL alpha-chymotrypsin in PBS (pH 7.4) and 
incubated at 37°C O.N. Samples were filtered using ultra filters with cut-off molecular weight 10 
kDa (Amicon Ultra, Millipore, Cork, Ireland). The absorbance was measured at 450 nm using a 
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microplate reader. The HEL concentration was expressed in nmol per milligram of creatinine 
(nmol/mg creatinine). 
Urinary 8-oxo-dG. 
Urinary 8-hydroxy-2′-deoxyguanosine (8-oxo-dG) was measured using the HT 8-oxo-dG ELISA Kit 
(Trevigen Inc. Gaithersburg, MD, USA) according to the manufacturer’s instructions. Briefly, 
filtered urine was diluted 1:20 with a buffer provided by the kit and added to a plate pre-bounded 
with 8-oxo-dG. Bound and sample 8-oxo-dG compete for binding to the anti-8-oxo-dG which was 
then added to the plate; the antibody fraction captured by the immobilized 8-oxo-dG in the plate 
was then detected by means of a HRP-conjugated secondary antibody. The assay was developed 
with tetramethylbenzidine substrate (TMB) and the absorbance was measured in a microplate 
reader at 450 nm. The 8-oxo-dG concentration was expressed in ng per milligram of creatinine. 
Protein carbonyl determination. 
Protein carbonyls were determined in plasma samples using the Protein Carbonyl ELISA kit (Enzo 
Life Sciences Inc. Farmingdale, NY, USA) following the manufacturer’s instructions. Plasma (5 µL) 
was derivatized with dinitrophenylhyidrazine (DNPH); derivatized proteins were then adsorbed to 
an ELISA plate. The adsorbed protein was then probed with biotinylated anti-DNP antibody 
followed by streptavidin-linked horseradish peroxidase. The absorbance was read at 450 nm using 
a spectrophotometer plate reader (Victor II, Pelkin-Elmer, Waltham, MA, USA). Plasma samples 
were assayed in duplicate, and protein carbonyl concentration was expressed as nanomoles of 
carbonyl groups per milligram of protein in the sample (nmol/mg). 
Plasma radical absorbance capacity (ORAC). 
The ORAC assay was carried out on a Fluoroskan FL® ascent (Thermo Fisher Scientific, Inc. 
Waltham, MA, USA) with fluorescent filters (excitation wavelength: 485 nm; emission filter: 538 
nm). following a previously published procedure [Pessina F. Et al. 2004]. Briefly, in the final assay 
mixture (0.2 mL total volume), fluorescein sodium salt (85 nM) was used as a target of free radical 
attack with 2,2′-azobis(2-amidino-propane) dihydrochloride (AAPH) as a peroxyl radical generator. 
Trolox, a water-soluble analogue of vitamin E, was used as a standard control and calibration 
curves were determined for 10, 20, 30, 40, 50 µM solution. Fluorescence measurements, carried 
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out at 37°C, were recorded at 5 min intervals, up to 30 min after the addition of AAPH. The ORAC 
values, calculated as difference of the areas under the quenching curves of fluoresceine between 
the blank and the sample, were expressed as Trolox equivalents (TE), pH = 7.4. All the assays were 
performed with three replicates. 
Superoxide dismutase (SOD) activity. 
SOD activity was determined in erythrocyte lysates by a competitive colorimetric inhibition assay, 
as previously described [Peskin AV, Winterbourn CC (2000)], (Abruzzo PM et al. 2010). This 
method is based on water-soluble tetrazolium salt, WST-1 (2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2
,4-disulfophenyl)-2H-tetrazolium,monosodium salt) (Dojindo Laboratories Co., Kumamoto, Japan), 
which produces a water-soluble formazan dye upon reduction with the superoxide anion 
generated by xanthine and xanthine oxidase (Sigma-Aldrich, St. Louis, MO, USA). SOD activity 
reduces the superoxide concentration and inhibits formazan formation. A SOD standard curve was 
obtained; different dilutions of erythrocyte lysates were assayed in order to find a sample dilution 
that falls within the range of standard curve linearity. Samples or standards (10 µL) were 
incubated for 20 min at 37°C with 100 µL reaction mixture containing 500 µM WST-1 and 75 µM 
xanthine in 50 mM CHES (2-N-(Cyclohexylamino) ethanesulphonic acid, pH 8.0. Finally, 10 µL 
Xanthine Oxidase (350 mU/mL) (Sigma-Aldrich, St. Louis, MO, USA) was added. Formazan 
formation was measured at 450 nm using a 96-well plate reader (Victor2 Multilabel Counter, 
Perkin-Elmer, Waltham, MA, USA). SOD concentration, expressed in units per milligram of 
hemoglobin, was determined using the SOD standard curve. 
Catalase activity. 
Catalase activity was determined in erythrocyte lysates using a method described by Ou and Wolff 
[Ou P, Wolff SP (1996)] based on the specific reaction of FOX-1 reagent (250 µM ammonium 
ferrous sulfate, 100 µM xylenol orange, 0,1 M sorbitol, 25 mM H2SO4) with H2O2 to yield a color 
complex having absorption maximum at 560 nm. The catalase causes decomposition of H2O2 such 
that residual H2O2 is inversely proportional to the activity of the catalase. One milliliter of 
erythrocyte lysates was incubated for 4 min. with 100 µL of 2.2 mM H2O2. Subsequently, 50 µL 
aliquots of the incubation mixtures were removed and rapidly mixed with 950 µL of FOX-1 reagent 
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in eppendorf tubes, which were then incubated at room temperature for 30 min. Absorbance was 
measured at 560 nm. Catalase concentration was expressed in units per milligram of hemoglobin. 
Erythrocyte plasma membrane fluidity. 
Erythrocytes plasma membrane fluidity was studied by determining the fluorescence anisotropy 
(reciprocal of fluidity) of two probes, TMA-DPH (1-(4-trimethylammoniophenyl)-6-phenyl-1,3,5-
hexatriene),and DPH (1-6-phenyl-1,3,5-hexatriene); used to evaluate membrane fluidity of the 
outer and the inner leaflet of cell membrane, respectively [Fiorini R, Curatola G (1991). The 
fluorescent probes were purchased from Molecular Probes Inc (Eugene, OR, USA). The incubation 
with TMA-DPH and DPH was performed as described by Sheridan and Block [Sheridan NP, Block ER 
(1988)]. Briefly, 3 µl of TMA-DPH and DPH (10−3 mol/L) were incubated for 5 min and 45 min 
respectively, at room temperature (23°C) with 2 ml of erythrocyte membranes (final concentration 
of 100 µg/mL) in 50 mmol/L Tris-HCl buffer solution, pH 7.4. Fluorescence intensities (100 readings 
each) of the vertical and horizontal components of the emitted light were measured on a Perkin-
Elmer MPF-66 spectrofluorometer equipped with two glass prism polarizers (excitation 
wavelength 365 nm, emission wavelength 430 nm). Sample temperature was maintained at 37°C 
using an external bath circulator (Haake F3). Steady-state fluorescence anisotropy (r) of TMA-DPH 
and DPH was calculated using the equation 
r = (IvG − Ih)/(Iv + 2Ih) 
where G is an instrument factor correcting for unequal detection of vertically (Iv) and horizontally 
(Ih) polarized light. 
Na+/K+-ATPase activity. 
Na+/K+-activated Mg2+-dependent ATPase activity was determined in cell membranes by the 
Kitao method [Kitao T, Hattori K (1983)]. ATPase activity was assayed by incubating 1 mL of 
erythrocyte plasma membrane after sonication (three bursts, 15 s each) at 37°C in a reaction 
medium containing MgCl2 (5 mmol/L), NaCl (140 mmol/L), KCl (14 mmol/L) in 40 mmol/L Tris-HCl, 
pH 7.7. The ATPase reaction was initiated with the addition of 3 mmol/L Na2ATP and stopped 20 
min later by the addition of 1 mL of 15% trichloracetic acid. The tubes were then centrifuged at 
1100 g for 10 min and the inorganic phosphate (Pi) hydrolysed from the reaction was measured in 
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the supernatant by a colourimetric assay using a KH2PO4 standard [Bradford M, 1976]. ATPase 
activity, assayed in the presence of 10 mmol/L ouabain, was subtracted from the total Mg2+-
dependent ATPase activity to calculate the activity of Na+/K+-ATPase. Protein concentration was 
determined as described by Bradford [Bradford M 1976], using serum albumin as a standard. The 
interassay variation was 5.3%, while the intra-assay variation was 8.1%. 
Lipoperoxide levels (TBARs) measurement. 
Lipoperoxide levels were evaluated using Cayman's thiobarbituric acid reactive substances (TBARs) 
assay kit. The product of fatty acid peroxidation, malondialdehyde (MDA), reacts with 
thiobarbituric acid (TBA) to yield a product that is measured fluorometrically. Membranes (100 mg 
of membrane proteins) were centrifuged at 3000 g for 15 min after the addition of 30% 
trichloroacetic acid, and 0.5 mL of the resulting supernatant was mixed with 1.1 mL of TBA reagent 
(equal volumes of 0.67% TBA aqueous solution and glacial acetic acid; v/v). The reaction mixture 
was heated for 60 min at 95°C in a sand bath. After cooling to room temperature, 5 mL of n-
butanol was added and the mixture was shaken vigorously for 2 min. Thereafter, samples were 
centrifuged at 4000 g for 15 min, then 150 µL from each vial were loaded to the plate for 
fluorometric assay and the fluorescence of samples and standards was read at an excitation 
wavelength of 530 nm and an emission wavelength of 550 nm. The lipid peroxide level (Lp) was 
expressed in terms of MDA content (µM), using 1,1′,3,3′-tetramethoxypropane as a standard. 
Sialic acid. 
Sialic acid content of RBC membranes was determined by the periodate thiobarbituric acid 
method of Denny et al. [Denny PC, et al. 1983]. Briefly, membranes (1 mg membrane proteins/mL) 
were first hydrolyzed in 0.05-mol/L H2SO4 in a final volume of 0.1 mL for 1 hour at 80°C to release 
SA [Warren L (1959)]. Standards and samples were both incubated with (assay samples) or without 
(correction samples) 0.25 mL periodate solution (0.025 mol/L periodic acid in 0.25 mol/L HCI) at 
37°C for 30 minutes [Sobenin IA, et al. 1988]. After reduction of excess periodate with 0.25 mL 
0.32 mol/L sodium thiosulfate, the reaction was completed by addition of 1.25 mL 0.1-mol/L 
thiobarbituric acid. The samples were heated at 100°C for 15 minutes and then cooled to room 
temperature. The product was extracted with acidic butanol and colorimetrically assayed with a 
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spectrophotometer at 549 nm. The readings of correction samples were subtracted from those of 
assay samples, thus corrected readings were obtained. 
Protein content was determined by Bradford method to normalize the sialic acid content using 
BSA as standard [Bradford M, 1976]. 
Erythrocyte membrane lipidomic analysis. 
The erythrocyte fatty acid membrane profile analysis was carried out as previously described, 
using the erythrocyte membrane pellet obtained by standard methods [Viviani anselmi c et al. 
2010]. For this study, selection of the erythrocyte fraction was made by modification of a 
literature procedure for the selection of aged erythrocytes (red blood cell age >3 months), with 
cells selected for high density and small diameter compared to the average erythrocyte population 
[van der Vegt SG et al. 1985]. 
One mL of whole blood was first centrifuged at 2000 g for 5 min to eliminate the plasma, and a 
second round of centrifugation was then carried out at 4000 g at 4°C for 5 min in order to yield a 
stratification by cell density. The bottom layer (2.5 mm from the bottom of tube) consisted of 
erythrocyte cells, which were evaluated for their diameter using a Scepter™ 2.0 Cell Counter 
(Merck Millipore, Milan, Italy) to characterize the cell selection from each blood sample. The 
results were also compared with the cell population obtained from standard density gradient 
separation [Rennie CM et al. 1979], [Corash LM et al. 1974]. Briefly, lipids were extracted from 
erythrocyte membranes according to the method of Bligh and Dyer [Bligh EG, Dyer WJ (1959]. The 
phospholipid fraction was controlled by TLC as previously described [Viviani Anselmi C et al. 2010], 
then treated with KOH/MeOH solution (0.5 M) for 10 min at room temperature and under stirring 
[Kramer JKG et al. 1997]. Fatty acid methyl esters (FAME) were extracted using n-hexane; the 
hexane phase was collected and dried with anhydrous Na2SO4. After filtration, the solvent was 
eliminated by evaporation using a rotating evaporator, and the thin white film of the FAME was 
subsequently dissolved in a small volume of n-hexane. Approximately 1 µL of this solution was 
injected into the GC. A Varian CP-3800 gas chromatograph, with a flame ionization detector and 
an Rtx-2330 column (90% biscyanopropyl-10% phenylcyanopropyl polysiloxane capillary column; 
60 m, 0.25 mm i.d., 0.20 µm film thickness) was used for the analysis. Temperature was held at 
165°C held for the initial 3 min, followed by an increase of 1°C/min up to 195°C, held for 40 min, 
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followed by a second increase of 10°C/min up to 250°C, held for 5 min. The carrier gas was helium, 
held at a constant pressure of 29 psi. Methyl esters were identified by comparison with the 
retention times of commercially available standards or trans fatty acid references, obtained as 
described elsewhere [Ferreri C et al. 2005]. 
Second study. Separation of blood components through Ficoll 
For each subjects enrolled in this second study were collected about 8 mL of blood in EDTA. The 
whole blood was centrifuged at 480 g for 10 minutes to allow the separation of plasma from the 
cellular component of the blood. The plasma was aliquoted into 1.5 mL eppendorf tubes and 
stored at -80 ° C for subsequent studies. The blood, devoid of plasma was diluted 1: 2 with 
phosphate saline buffer (PBS 1X) and then the solution was layered on a Ficoll (Histopaque-Sigma), 
previously aliquoted into two tubes of 15 mL. Afterwards was carried out a second centrifugation 
at 260 g for 35 minutes in order to separate the white blood cells from erythrocytes. At the end of 
the centrifuge, the blood is separated into the following components: plasma, a layer of 
mononuclear cells, the Ficoll and finally granulocytes and erythrocytes. 
With the help of a pasteur pipette, taking care not to aspirate the Ficoll, the ring of mononuclear 
cells present in the two tubes was collected and transferred into two tubes of 15 mL. In order to 
eliminate any traces of Ficoll, the blood mononuclear cells were resuspended in PBS (10 ml) and 
subsequently centrifuged at 230 g for 10 minutes. Three washes were performed; after the last 
wash, the PBS 1X was aspirated and the cell pellet on the bottom of the two tubes was put 
together. A part of the white blood cells has been stored at -80 ° C and one part was used for the 
analysis of protein glutathionylation. Red blood cells were subsequently processed; in particular 
the red blood cells of one of the two tubes were used to isolate erythrocytes membranes (see next 
paragraph), while the remaining erythrocytes were were resuspended in PBS 1X (10 ml) and 
subsequently centrifuged at 1400 rmp for 10 minutes. Three washes were performed; after the 
last wash the red blood cells have been used to evaluate the distribution of phosphatidylserine in 
the erythrocyte membrane, the glutathionylation of proteins and for the analysis of the 
morphology of red blood cells by scanning microscopy (SEM) and transmission (TEM). 
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Preparation of erythrocyte membranes 
The red blood cells were washed three times with 1X PBS (10 ml) supplemented with 5 mM 
glucose and, subsequently, were centrifuged at 1500 xg for 10 minutes. After the last washing, 1 
mL of red blood cells was lysed with 15 mL of lysis buffer consisting of 5 mM phosphate buffer at 
pH 8 and 1 mM EDTA. For optimal lysis, the sample was mixed vigorously and subsequently was 
centrifuged at 27,500 g for 20 minutes at 4 ° C using a chilled ultracentrifuge and paying attention 
to balance the test pieces. At the end of the centrifuge, the supernatant rich hemoglobin has been 
cleared; the pellet containing the membranes, has been washed to remove traces of hemoglobin. 
The membranes, in fact, were resuspended in 15 mL of lysis buffer and centrifuged as before; 4 
washes were performed at the end of which was obtained a pellet of colorless membranes 
(haemoglobin-free). Al pellets are added 5 μL of protease inhibitors for each mL of the obtained 
membranes. These were stored at -80 ° C and subsequently were used to measure the amount of 
cholesterol and to evaluate the protein expression of the subunits of the Na-K ATPase. 
Assessment of the levels of cholesterol in the membranes of erythrocytes 
The quantification of cholesterol in the membranes of red blood cells was carried out by a 
colorimetric assay. It was determined the concentration of total cholesterol, consisting of the sum 
of the concentration of free cholesterol and cholesteryl ester. For this reason, in the assay was 
used an enzyme, cholesterol esterase, which hydrolyze cholesterol esters to cholesterol. The assay 
is based on the oxidation of cholesterol by the enzyme cholesterol oxidase; this reaction produces 
H2O2 (hydrogen peroxide) which reacts with a colorimetric probe. The course of the colorimetric 
reaction is followed by measuring the absorbance at 570nm.  A calibration curve was obtained by 
making serial dilutions of a standard of cholesterol at a known concentration. The amount of 
cholesterol present in the samples of red cell membrane is obtained by interpolating the 
absorbance value in the standard curve. 
For the preparation of the standard we diluted 20 μL of cholesterol standard (2 μg/μL) with 140 μg 
of Assay Buffer cholesterol obtaining a solution with a cholesterol concentration of 0.25 μg/μL. 
Were added 0, 4, 8, 12, 16, and 20 μL of the solution of cholesterol standard in a 96-well plate in 
order to have 0, 1, 2, 3, 4, and 5 μg of cholesterol standard per well. It was finally added to each 
well Assay Buffer until to get a volume of 50 μL. For the preparation of samples were used 5 μL of 
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erythrocyte membranes which have been brought to a final volume of 50 μL with Assay Buffer. 
The amount of membranes (5 uL) was determined in a preliminary experiment in which, for a 
given sample, we used scalar amounts of membranes in order to find the volume of membranes 
whose amount of cholesterol fell within the linearity range of the standard curve. All samples and 
standards were prepared in duplicate. Once the standards and the samples were plated in each 
well a reaction mix was added, consisting of 44 μL of Assay Buffer, 2 μL of probe, 2 μL of enzyme 
mix (containing cholesterol oxidase) and 2 μL of Cholesterol esterase. The plate was incubated for 
60 minutes at 37 ° C in the dark. After incubation, the absorbance was measured at 570 nm using a 
plate reader (Victor II, Perkin-Elmer). The amount of cholesterol was calculated by subtracting the 
value of the absorbance of the blank to all the absorbance values obtained. For both the standard 
and the samples the average of duplicates has been calculated. The standard curve  was built by 
reporting on the abscissa the quantity, in mg, of cholesterol standards, and the absorbance on the 
ordinate axis. The absorbance values of each sample were interpolated in the standard curve, thus 
obtaining the amount of cholesterol in the unknown sample expressed in μg. The latter was 
divided by the volume in the well (50 μL) and multiplied by the dilution factor. This concentration 
value, expressed in μg/μL, was normalized to the protein concentration determined by Bradford 
method (Bradford 1976). 
Evaluation of glutathionylation in red blood cells and white blood cells 
To measure the amount of protein glutathionylated in samples of white blood cells and red blood 
cells a colorimetric assay has been used (S-Glutathionylated -Detection Kit, Cayman). The assay is 
based on the detection of glutathionylated proteins by the addition of specific reagents which 
determine: 1) the blocking of the free thiol groups (-SH) present in the protein; 2) the enzymatic 
cleavage of glutathionylation sites with formation of new thiol groups; 3) recognition of the new 
thiol groups by colorimetric reaction . 
In particular, the assay is based on the modification of free thiol groups (-SH) of proteins by the 
addition of a reagent, the PSSG Blocking Reagent, supplied by the kit. In this way, the free thiol 
groups are protected from subsequent step of enzymatic reduction. In fact, the addition of 
another component of the kit, PSSG Reduction Reagent, allows the enzymatic cleavage of all the 
glutathionylated cysteine residues, thereby generating new free thiol groups. To detect the latter, 
the PSSG Labeling Reagent is added, which allows the biotinylation of thiol groups that will be 
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quantified by using the binding of an antibody streaptavidina FITC conjugate. The fluorescence 
signal will be analyzed by flow cytometry. The assay, in addition to the test sample (test tobe B), 
involves the preparation of a negative control (test tube A) and a positive control (test tube C). In 
particular, PSSG Reduction Reagent is not added in the test tube A, thus preventing the formation 
of new free thiol groups that can react with biotin. The preparation of the specimen A, without the 
reducing agent, allows us to obtain the minimum of the staining. The test tube C, however does 
not include adding PSSG Blocking Reagent, thus making accessible all the thiol groups of proteins 
the binding to biotin; therefore, this control allows to get the most of the staining. The white 
blood cells of autistic and control subjects were resuspended in 1.5 mL of 1X PBS and transferred 
to 3 eppendorf tubes  in order to have a negative control (tube A), a positive control (test tube C) 
and the sample to be tested (test tube B). White blood cells were centrifuged at 300 g for 5 min. 
The supernatant was cleared and the pellet was fixed with 100 μL of 3.7% formaldehyde in cold 
PBS for 10 minutes at room temperature. Subsequently, the cells were washed with PBS by 
centrifuging the tubes at 200g for 5 min. To block free thiol groups of proteins, the PSSG Blocking 
Reagent has been prepared, by dissolving the powder in 100 μL of N, N-dimethylformamide 
(DMF); this solution was then diluted by adding it to 9.9 mL of Assay Buffer. One hundred 
microliters of Blocking Reagent were added to the tubes A and B, while in the tube C were added 
100 μL of Assay Buffer. The samples were incubated for 30 minutes at room temperature. After 
the indicated time, the Blocking Reagent was eliminated by centrifuging the tubes at 200 g for 5 
minutes; subsequently, the samples are washed twice with 100 μL of Assay Buffer. The same 
procedure was performed for the red blood cells, however, making some changes concerning the 
fixation and washes. In fact, the red blood cells were fixed in 100 μL of 0.025% glutaraldehyde in 
PBS for one hour at room temperature. All washes were performed with 1X PBS instead of Assay 
buffer. These protocol changes were necessary because of the extreme fragility of red blood cells 
that were undergoing lysis in the presence of formaldehyde and Assay buffer. Once deleted the 
trace of the Blocking Reagent, to each sample B and C of red blood cells or white were added 100 
μL of PSSG Reduction Reagent, prepared by adding 1.1 mL of sterile water to the powder of the 
kit, whereas in the test tube A were added 100 μL of Assay Buffer. The samples are incubated for 
15 minutes at 37 ° C. After incubation, the tubes were centrifuged at 200 g for 5 minuiti. After the 
supernatant aspiration, tubes A B C were washed twice with 100 μL Assay Buffer (white blood 
cells) or PBS 1X (red blood cells). One hundred microliters of Labeling Reagent, prepared by 
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dissolving the powder of the kit in 10 μL of DMF and adding this solution to 1990 μL of Assay 
Buffer, was added to all samples A, B and C. The tubes were incubated for 1 hour at room 
temperature. After incubation 3 washes were performed with Assay Buffer (white blood cells) or 
PBS 1X (red blood cells) centrifuging the tubes at 300 g for 5 minutes. Finally, 100 μL of PSSG 
Detection Reagent II (FITC) prepared by diluting the stock solution in 1 mL of assay buffer, were 
added to the pellet of white blood cells or red blood cells; the samples are incubated for 1 hour. 
Next, for each sample were carried out two washes with 100 μL of Assay Buffer (white blood cells) 
or PBS 1X (red blood cells) by centrifugation at 300 g for 5 min. After the last wash we 
resuspended samples of red blood cells in 500 μL of 1X PBS, while the white blood cells in 400 μL 
of assay buffer. The levels of glutathionylation protein were measured by flow cytometry; the 
reading parameters of the instrument have been set with a sample of white blood cells and a 
sample of red blood cells. 
 
Evaluation of Phosphatidylserine 
The annexin V is a calcium-dependent protein which has a high affinity for phosphatidylserine (PS), 
and it is used as a probe to detect the phosphatidylserine (PS) present on the cell surface, an event 
that occurs in apoptosis as well as in other forms of cell death. In fact, in physiological conditions, 
the PS is a phospholipid distributed more on the cytosolic side of the membrane. Any differences 
in the distribution of PS on the cell surface at baseline or after stress were detected by using the  
Annexin-V-FLUOS staining kit (Roche) in red blood cells. 
For the preparation of samples were used 5 μL of red blood cells diluted in 10 mL of  PBS 1X. One 
milliliter of this suspension was transferred into three 1.5 mL eppendorf: the tube 1 is the control 
(CTR), which contains the red blood cells not labeled with annexin V-propidium iodide; the tube 2 
is the sample containing red blood cells labeled with annexin V-propidium iodide; the red blood 
cells of the test  tube 3 are incubated with hypertonic solution of NaCl 9%, in order to damage the 
cells, and subsequently, were labeled with annexin V-propidium iodide. 
Once prepared the three test tubes with the suspension of red blood cells, the tube 3 was 
centrifuged for 5 min at 3.0 rpm; the supernatant was aspirated and the pellet of red blood cells 
was resuspended in 1 ml of 9% NaCl solution. The sample was incubated at room temperature for 
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10 minutes. After incubation, we centrifuged the three tubes for 5 min at 3.0 rpm, we aspirated 
supernatant and resuspended the pellet of the tubes 2 and 3 in 100 L of solution containing 
annexin V and propidium iodide, while the tube 1 was resuspended in 100 L of buffer provided by 
the kit. Finally, the samples were incubated for 15 min at room temperature. After incubation we 
transferred 100 L samples in tubes suitable for cytofluorimetric analysis, where previously they 
had been aliquoted 500 L of Buffer kit. It was then carried out the reading of the samples by flow 
cytometry. The number of annexin positive cells  in autistic patients and in control subjects were 
analyzed by statistical tests. 
Statistics 
All experiments were carried out in duplicate or triplicate and were usually repeated three times. 
To compare Au and TD groups, normality tests were applied to all numeric variables, following 
which appropriate parametric tests (ANOVA, Student's t for independent data) or the 
nonparametric equivalent (Wilcoxon-Mann-Whitney) were used. Non-parametric correlation 
(Spearman's rho) was used to correlate clinical features and biochemical data in the Au group 
(non-parametric ANOVA for cognitive/developmental level). Differences were considered 
significant at p<0.05. 
To account for multiple testing we used the Benjamini and Hochberg false discovery rate (FDR) 
[Benjamini Y, Hochberg Y (1995)]. Statistical analysis was performed using SAS v. 9.2. 
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3.3 Results 
This study focused on three issues: oxidative stress markers, erythrocyte (membrane functional 
and structural features, erythrocyte morphology),  Na K ATPase activity (erythrocyte and 
lymphocyte membrane). 
Oxidative stress markers in urine and plasma and antioxidant enzymes activities in erythrocytes. 
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Peroxidation of arachidonic acid causes 
membranes to release 8-isoprostane, a 
prostaglandin-F2-like compound.  
Oxidized arachidonic acid or other 
omega-6 fatty acids, such as linoleic 
acid, may also react with protein lysine 
residues, yielding HEL.  
Both 8-isoprostane (p<0.01; pFDR = 
0.0278) and HEL (p<0.05; pFDR = 0.076) 
were found in higher amount in the 
urine of Au than in the urine of TD 
children (+47% and +45%, 
respectively).  
However, the amount of 8-oxo-dG, 
derived from the oxidation of nucleic 
acid bases by free radicals, did not 
significantly differ between the two 
groups. 
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Plasma levels of carbonyl groups (an 
oxidative modification of proteins) and 
plasma radical absorbance capacity (a 
measure of the antioxidant capacity, 
which is reduced by free radicals) did not 
differ between the two groups.  
 
Similarly, neither SOD nor catalase enzymatic activity 
measured in erythrocytes were found to differ between the 
two groups.  The evaluation of erythrocyte catalase activity 
was repeated in the second study by Prof De Franceschi  with 
a different method, which confirmed the absence of 
significant differences between AU and TD children. 
Moreover, the expression of the chaperon HSP17 was 
evaluated by WB in erythrocytes and found to be the same in 
the two groups of children. 
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The lymphocyte membrane fluidity did not differ between Au and TD children (prof Mazzanti, data 
not shown). 
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  Fig 10  DPH 
TMA-DPH and DPH are two probes used 
to evaluate membrane fluidity of the 
outer and the inner leaflet of cell 
membrane, respectively. Taking into 
account that TMA-DPH and DPH 
fluorescence anisotropy is inversely 
related to the fluidity of the 
microenvironment where the probe is 
located, it was found that erythrocyte 
membrane fluidity was decreased in Au 
with respect to TD. The decrease reached 
the statistical significance (p<0.05) for 
both the outer and inner membrane 
(pFDR = 0.0368, pFDR = 0.0469, 
respectively). 
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The presence of carbonyl groups was evaluated by WB, following DNP derivatization. Carbonyl 
groups were found to be increased in erythrocytes from AU children.  
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Fig 12    Sialic acid 
TBARS assay measures MDA generated from the decomposition of primary and 
secondary lipid peroxidation products. TBARS were found to be significantly higher 
(+41%) in the erythrocyte membrane from Au children in comparison with those from 
TD children (p<0.01; pFDR = 0.0125). 
Sialic acid levls in erythrocyte did not differ between Au and TD. 
 
Fig.13  Carbonyl Groups (erythrocyte) 
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Peroxiredoxin II and Peroxiredoxin I 
Peroxiredoxin II and Peroxiredoxin I were evaluated by Prof De Franceschi (University of Verona). 
Peroxiredoxin II levels were found  to be elevated (p<0.01) in Au group when compared to TD 
children (Au: mean 0.99,  SD 0.55, range 0.27-1.77; TD: mean 0.38,  SD 0.32, range 0.06-0.98). 
Peroxiredoxin I did not differ significantly between the two groups. 
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Fig. 14: Prx2/Actin and Prx1/actin 
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Fatty acids composition of erythrocyte membrane 
The percentage of oleic, palmitoleic and vaccenic acids and, in general, total MUFA were increased 
in Au with respect to TD children. This caused also a decrease in SFA/MUFA ratio in Au with 
respect to TD children (p<0.05; pFDR = 0.07329). 
The relative amount of the different PUFA was also altered, since EPA and DHA-ω3 acids were 
decreased in Au children (−16%, p<0.05, pFDR = 0.10308 and −14%, p<0.01, pFDR = 0.0722, 
respectively), causing an increase in ω6/ω3 ratio (+16%, p<0.05, pFDR = 0.07329).  
The fatty acid composition of the erythrocyte membrane has been evaluated also in the group of 
children evaluated in the second study. The results confirm the decrease of DHA and a significant 
increase of the ω6/ω3 ratio in AU children.   
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Assessment of the levels of cholesterol in the membranes of erythrocytes 
Autistic children showed significantly lower cholesterol levels than children with typical 
development. These data are in line with those reported by Schengrund (Schengrund et al., 2011). 
As a whole, these data contribute to point out the presence of impairment in the membrane 
hydrophobic double layer.  On the other hand, circulating fatty acids were found to be in the 
normal range. 
 
Fig 16: erythrocyte membrane cholestrol 
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Evaluation of glutathionylation in red blood cells and white blood cells 
The data obtained have shown that the glutathionylation of proteins in red blood cells and white 
blood cells did not show significant differences in between autistic children than in control 
subjects. 
 
  Fig. 17:    Glutathionylation of protein  in red blood cells 
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  Fig. 18:    Glutathionylation o protein in red blood cells 
Analysis of levels of protein glutathionylation performed by Western Blot in the 
proteins extracted from erythrocyte membranes of autistic subjects (AUT) and 
control subjects (CTR). 
A:  Western Blot performed with the Antibody anti-GSH. 
B: the total protein that are transferred on nitrocellulose and are detected by UV  
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Evaluation of Phosphatidylserine 
In untreated erythrocytes of autistic children we showed a trend of decrease of Annexin-positive 
cells when compared to controls. The decrease is evident when the red cells are treated with a 
hypertonic solution (NaCl 9%) (see figures below). 
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Erythrocyte Na+/K+-ATPase activity ( Prof Laura Mazzanti lab, Ancona) 
The activity of Na+/K+-ATPase, an active ion transporter localized in the plasma membrane, was 
markedly decreased (−66%) in Au in comparison with TD (p<0.0001; pFDR<0.0001), with no 
overlapping values between Au and TD (Au min. 1.41, max. 3.38; TD min. 5.27, max. 10.75). 
 
Lymphocyte Na+/K+-ATPase activity (Prof Laura Mazzanti lab, Ancona) 
The activity of lymphocyte membrane Na+/K+-ATPase was markedly decreased (−40%) in Au in 
comparison with TD (p<0.0001), with no overlapping values between Au and TD (Au min. 0.49 , 
max. 0.840, mean 0.646, SD 0.12 ; TD min. 0.895, max. 1.253, mean 1,065, SD 0.12 ). 
 
 
 
 
  
 
 
 
 
While NKA activity was found to be significantly decreased in leukocytes from AU children, 
similarly to what was observed in erythrocytes, no difference in leukocyte membrane fluidity was 
found between the two groups (data not shown), at variance with what observed in erythrocytes. 
This suggests that membrane fluidity does not affect NKA activity 
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  Fig. 19:    Na+/K+ ATPase activity 
49 
 
 
Evaluation of erythrocyte NKA subunits by Western Blotting 
We attempted to evaluate erythrocyte NKA subunits by Western Blotting, by means of the primary 
antibodies, which had been used in a published paper (Hoffman JF, et al. 2002). Secondary 
antibodies were purchased from Pierce. Pre-cast gel (Mini-PROTEAN TGX Stain Free Gel, BioRad), 
4-15% acrylamide were used. Following transfer, membranes were visualized in order to evaluate 
equal loading. The figure below  shows WBs developed from two samples used as positive controls 
in preliminary experiments, i.e. normal erythrocytes and skeletal muscle. Apart from subunit α2, 
which is not expected to be present in erythrocytes, the other subunits were expected to be found 
as single protein bands. However, results were disappointing. In fact, the anti-subunit α3 antibody 
marks a high number of aspecific proteins; the anti-subunit α1 antibody does not recognize any 
protein; the anti- subunit β2 antibody reacts very weakly with erythrocytes; the anti-subunit β3 
antibody is apparently the only one reacting with a single protein in erythrocytes; the anti-subunit 
β1 antibody reacts with multiple aspecific  proteins; finally, the antibody directed against the 
regulatory subunit  Fxyd1 does not recognize any protein.  
We now purchased new anti-subunit α antibodies from Santa Cruz, hoping that they will work 
better and we’ll complete the evaluation of all samples. 
 
+    
 
 
 
 
 
 
 
 
  Fig. 19:    Western Blot 
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Gene expression of NKA subunits in leukocytes 
We then evaluated the gene expression of NKA subunits in leukocytes, which are nucleated and 
synthesize RNA, at variance with erythrocytes. RNA was extracted from leukocytes from five AU 
and five TD children; RNA was quality assessed, reverse transcribed and evaluated by qRT-PCR 
using custom-designed primers. The RNAs coding for all NKA subunits were evaluated and their 
amount reported to those of housekeeping genes G6PDH and actin. Subunit α2 RNA was not 
detectable. Histograms in Figure below show the absence of significant differences between AU 
and TD children in the amount of RNAs coding for the other subunits. The evaluation will be 
repeated in leukocyte RNA from at least 5 more AU and 5 more TD children.  
 
  
 
Fig. 20: gene expression sub units           
Na+/K+ ATPase    
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Erytrocyte Beta Actin levels 
Erythrocyte Beta Actin levels were independently evaluated by De Franceschi (Verona) and by our 
group: the results showed no differences between Autistic and control group. 
Analysis of the levels of Beta Actin  was performed by Western blot in the proteins extracted from 
erythrocyte membranes of autistic subjects (AUT) than in control subjects (CTR). 
 
Fig 21 A  Western blot 
performed with the anti-beta 
actin. 
 
Fig 21 B The total protein 
that are transferred on 
nitrocellulose and that 
are detected by UV  
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Correlation between Au Clinical Features and Biochemical Data 
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rho) was used to correlate clinical 
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group. 
 CARS global scores were inversely 
related with ω6 arachidonic acid (p<0.05; 
pFDR = 0.31104) and PUFA (p<0.05; pFDR 
= 0.18450).  
 
 
 
 
 
 
 
 
 
TMA-DPH was correlated with age 
(p<0.01 pFDR = 0.2376).  
 
 
 
 
CARS body use item scores (stereotypes) 
were not significantly related to any 
biochemical marker. 
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CARS activity level item scores (hyperactivity) 
were negatively correlated with TMA-DPH 
(p<0.01; pFDR = 0.03720), oleic acid (p<0.05; 
pFDR = 0.15035), ω6 arachidonic acid (p<0.05; 
pFDR = 0.15035), MUFA (p<0.05; pFDR = 
0.11728) and PUFA (p<0.01; pFDR = 0.03720), 
and directly correlated with SFA (p<0.001; pFDR 
= 0.00930), palmitic acid (p<0.01; pFDR = 
0.03720), SFA/MUFA (p<0.001 pFDR = 0.03720). 
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When only cognitive/developmental impaired Au children (n: 19) were considered, the non 
parametric ANOVA revealed that the level of cognitive/developmental impairment was inversely 
related with ω6 arachidonic acid (p<0.05; pFDR = 0.33199), and directly related with 8-isoprostane 
(p<0.05; pFDR = 0.33199), total SFA (p<0.05; pFDR = 0.33199) and palmitic acid (p<0.05; pFDR = 
0.33199), while cognitive impairment and total PUFA showed only a trend of inverse correlation (p 
= 0.0553; pFDR = 0.33199).  
 
 
 
 
 
 
 
 
 
Moreover Peroxiredoxin I levels, evaluated in 8 Au children, inversely correlate with clinical 
features, in particular with numbers of CARS items where score is ≥3 (expression of severity of the 
symptoms) and with ADOS score. 
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Correlations between biochemical features 
The correlation between the evaluated biochemical parameters was beyond the scope of our work. Below I 
show the graphs of some correlations that were significant. These data need to be confirmed and 
elaborated in subsequent studies. In particular Peroxiredoxin II values are highly (p<0.001) and inversely 
correlated with DHA content of erythrocyte membrane (but, interestingly, only in autistic group); 
consequently they are directly correlated with omega6/omega3 ratio and inversely with omega 3 index 
(defined as EPA+DHA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Prx2/DHA
0.0 0.5 1.0 1.5 2.0
0
1
2
3
4
5
Prx2/actin
D
H
A
P<0.0001           
 Prx2/DHA control group
0.00 0.25 0.50 0.75 1.00 1.25
0
1
2
3
4
5
6
7
Prx2/actin
D
H
A
0.0 0.5 1.0 1.5 2.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10.0
10.5
Prx2/actin
O
M
E
G
A
 6
/O
M
E
G
A
 3
P<0.0001           
0.0 0.5 1.0 1.5 2.0
3.0
3.5
4.0
4.5
5.0
5.5
Prx2/actin
O
m
e
g
a
 3
 I
n
d
e
x
P<0.0001           
56 
 
 
3.4 Discussion 
The present project was aimed at increasing the knowledge of the biological basis of Autism 
focusing on three issues: oxidative stress, erythrocyte membrane features and morphology,  
Na+/K+ATPase activity of erythrocyte and lymphocyte membranes. 
There is increasing evidence that autistic patients show excessive ROS production and several 
studies reported the presence of different peripheral biomarkers of oxidative stress [Frustaci et al.,  
2012; Geier DA and Geier MR, 2008; Bradstreet JJ, et al. 2010]. However, the great heterogeneity 
of the syndrome makes it difficult to assess whether this finding is occasional and whether it is 
restricted to a sub-group of patients. Moreover, not all oxidative stress markers appear to be 
altered in patients, and it is still unknown whether oxidative stress, if really present, is secondary 
to a generic inflammatory status or due to genetic alterations still to be recognized. In addition, 
most researchers addressing this problem have a tendency to evaluate few markers at a time, thus 
making it very difficult to compare data obtained in different patient’s subgroups [Meguid NA, et 
al., 2011; Pecorelli A et al., 2012].  
To our best knowledge, this is the first study, which evaluated, at the same time, a wide range of 
different but strongly related biological biomarkers in a group of Au children that underwent a 
rigorous clinical characterization.  
A far as concern the oxidative stress, we found, in Au children compared to TD children, a 
significant increase in TBARS, 8-isoprostane and HEL, which are markers of lipid peroxidation. The 
increase in carbonyl groups in erythrocyte membrane proteins of AU children highlights a direct 
result of oxidative injury. No significant differences were found in the oxidative biomarkers 8-oxo-
dG and ORAC. This finding suggests that the oxidative stress-related phenomena are localized 
mainly at the cell surface. Systemic involvement is suggested by detection of these markers both 
in urine and in erythrocytes. The expression of two antioxidant enzymes – namely peroxyredoxin 1 
and 2 (Prx1 e Prx2), was evaluated in the erythrocyte membrane by Prof De Franceschi research 
group. No difference was found for Prx1, while Prx2 was found to be significantly increased in AU 
children. This confirms that erythrocytes from AU children are the target or the site of oxidative 
stress. These pro-oxidant conditions usually favor the release from the erythrocyte membrane of 
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microvescicles carrying Prx2, which contributes to the general anti-oxidative defenses of the body. 
As a confirmation of the relation between oxidative stress and Prx2, statistical analysis showed a 
direct correlation between Prx2 amount and ω6/ω3 ratio in AU children. 
The fatty acid composition of the brain and neural tissues is characterized by high PUFA 
concentrations, which play a very important role in signal transduction [Kim HY,2007], neuro-
inflammation [Orr SK, Bazinet RP, 2008] and cellular repair and survival [Bazan NG, 2005]. 
Erythrocyte membrane fatty acid composition is a very sensitive indicator of the status of 
different tissues and may reflect the fatty acid composition of brain [Makrides M etal., 1994]. In a 
number of neurodevelopmental conditions, including Attention Deficit Hyperactivity Disorder 
(ADHD) and dyslexia, reduced concentrations of erythrocyte membrane PUFA have been reported 
[Richardson AJ, Ross MA (2000)]. Moreover, a polymorphism in the gene cluster associated with 
the fatty acid desaturase-2 gene (FADS2) for Delta 6-desaturase (the rate-limiting step in PUFA 
synthesis) was described in patients with ADHD [Brookes KJ et al., 2006; Schaeffer L, et al.2006] 
pointing to a possible correlation between membrane fatty acid composition and hyperactivity.  
In our study, a significant increase of erythrocyte membrane MUFA and of ω6/ω3 ratio (due to a 
decrease in EPA and DHA) was shown. These results are partially superimposable to those 
reported by Bell et al. [Bell JG et al., 2010]. Alteration in membrane lipid composition was not 
related to dietary habits, since they did not significantly differ between Au and TD, as evidenced 
by the Food Questionnaire. On the other hand, oxidative stress is not a likely explanation for the 
specific decrease of the ω3, since this would have also affected the ω6 PUFA family. The observed 
imbalance in ω6/ω3 ratio may lead to the proinflammatory status reported previously in ASD 
children [Rose S, et al. 2012], [Vargas DL et al., 2005; Rossignol DA, Frye RE (2012)]. The significant 
increase in MUFA may be representative of a feedback remodelling of erythrocyte membrane lipid 
composition. It is interesting to note that a study on adipocyte membranes showed DHA loss 
coexistent with MUFA increase [Pietiläinen KH et al., 2011].  The data about lipidomc profile were 
published in 2013 (Ghezzo et al., 2013); very interestingly, the reduction of DHA and the increase 
of ω6/ω3 ratio was confirmed in the second study. 
It has not escaped our notice that the erythrocyte membrane fluidity decrease we observed 
cannot be directly explained on the ground of these alterations in fatty acid composition. 
Schengrund et al. [Schengrund CL et al., 2012] recently reported a decrease in cholesterol and a 
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related increase in GM1 ganglioside in erythrocyte membranes from ASD children, which could 
affect membrane fluidity. However, we failed to observe any change in membrane sialic acid - a 
component of GM1 ganglioside, in Au patients, but we confirmed the decrease of choleterol in 
erythrocyte membranes. The reduction of membrane fluidity was not observed in lymphocytes. 
 
Cholesterol is an essential component of cell membranes of mammals. It is a molecule of the class 
of sterols which plays a significant role in the human physiology; in particular plays an important 
role in intracellular transport, in cell signaling, and in the maintenance of membrane fluidity, 
inserted between the two layers phospholipid with -OH groups oriented close to the polar heads 
of the phospholipids. Because of its structure has hydrophobic characteristics and is thus poorly 
water soluble. It is present in all tissues and in greater amounts in the brain, in the bile and in the 
blood. Cholesterol is synthesized mainly in the liver and is excreted in the bile, after 
transformation into bile acids and then into bile salts. Cholesterol circulates in the blood as free 
and  as esterified with long chain fatty acids. 
Has been shown that an altered cholesterol homeostasis can affect neuronal development and 
synaptogenesis leading to nervous system dysfunction (Pani A et al., 2010; Linetti A et al., 2010). In 
addition, recent evidence suggests that an imbalance in the homeostasis of cholesterol 
contributes to the development of a chronic inflammatory state. Alterations of cholesterol are also 
highlighted in patients with autism. In fact, in a study conducted by Tierney in 2006 was shown a 
decrease of cholesterol levels in the serum of patients with autism. Moreover, in a previous work 
conducted by Schengrund (et al., 2011) has been shown a reduction in the levels of cholesterol in 
erythrocyte membranes of a group of 20 autistic children compared to 20 control children. 
However, the authors point out that only 19% of children with autism show significantly lower 
levels of cholesterol than controls.  Cholesterol has an important role in maintaining the fluidity of 
membranes. In our study autistic children showed significantly lower cholesterol levels in 
erythrocyte memebrane than children with typical development. These data are in line with those 
reported by Schengrund (Schengrund et al., 2011). The presence of low levels of cholesterol in 
children with autism may not only affect the fluidity of erythrocyte membranes, but may have a 
role in the development of the nervous system and may be associated with certain behaviors 
characteristic of autism. To better understand the possible effect of the altered amount of 
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cholesterol, we must keep in mind that it contributes to the formation of lipid rafts along with 
gangliosides. It will therefore be important to evaluate the concentration of these lipids in order to 
understand whether the structure of the lipid rafts could be altered as far as concern its structure 
and its funcion. In particular, it is in progress the quantification of sphingomyelin in the 
membranes of the erythrocytes. 
The S-glutathionylation is a post-translational modification of proteins which consists in the 
reversible formation of mixed disulfide bonds between cysteine residues and glutathione (GSH). 
The glutathionylation is involved in a series of cellular events, such as the stabilization of 
extracellular proteins, the protection of proteins, the irreversible oxidation of cysteine residues, 
the regulation of enzyme activity and the response to oxidative stress. These data led us to 
evaluate, in red blood cells and white blood cells of people with autism and those with typical 
development, the total protein glutathionylation, as a possible marker of damage to proteins. The 
data obtained have shown that the glutathionylation of proteins in red blood cells and white blood 
cells did not show significant differences in between autistic children than in control subjects. 
Annexin V is a membrane protein that recognizes phosphatidylserine; this is a phospholipid that 
under physiological conditions is found almost exclusively on the cytoplasmic side of the 
membrane. However, following a cellular stress, a significant part of phosphatidylserine is exposed 
on the extracellular side of the cell membrane. This reaction can be monitored with the use of the 
Annexin protein conjugated to a fluorophore (FITC). We evaluated the positivity of the 
erythrocytes to Annexin V in basal conditions or in response to osmotic stress in order to compare 
the distribution of phosphatidylserine in the erythrocyte membrane of autistic children and 
control. In untreated erythrocytes of autistic children we showed a trend of decrease of Annexin-
positive cells when compared to controls. The decrease is evident when the red cells are treated 
with a hypertonic solution (NaCl 9%) . This result indicates that there may be a decrease in flippase 
activity and/or a decreased amount of PS itself. Further studies will be needed in order to assess 
the amount of phosphatidylserine in erythrocyte membranes. Noteworthy, the decrease in PS 
amount, if confirmed, might account for the highly frequent erythrocyte morphological 
abnormalities we found.  
Na+/K+-ATPase (NKA) maintains intracellular gradients of ions that are essential for cellular 
activities. Despite the crucial role of NKA in cellular metabolism and the fact that it accounts for 
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approximately 30% of the total body energy consumption and for 50% brain energy consumption, 
very little is known about NKA in autism. In a mouse model of Angelman Syndrome, a 
neurodevelopmental disorder associated with autism, an intrinsic alteration of membrane 
properties of pyramidal neurons in hippocampal area CA1 has recently been observed [Kaphzan 
H,et al., 2011]. Alterations were also observed in resting membrane potential, threshold potential, 
and action potential amplitude correlated with significant increases in the expression of the α1 
subunit of Na+/K+-ATPase [Kaphzan H,et al., 2011]. In postmortem tissues from different brain 
regions of autistic subjects, a specific increase in NKA in the frontal cortex and cerebellum was 
found. The authors suggested that such increase might be due to compensatory responses to 
increased intracellular calcium concentration in autism [Ji L, et al. 2009]. 
As far as concern the Na+, K+ activity,  we obtained the following results: a) NKA activity is 
reduced not only in erythrocytes but also in leukocytes from AU children; b) at variance with 
erythrocytes, leukocyte membrane  does not display a decrease in fluidity, a results that points to 
the lack of relation between the decreased NKA activity and membrane fluidity; c) subunit gene 
expression does not seem to differ between the two groups of children.  
The very significant reduction of erythrocyte NKA in Au compared to TD is in keeping with a similar 
report by Kurup and Kurup [Kurup RK, Kurup PA (2003)]. There is no overlap between the range 
values of the two groups, both as regards erythrocyte and lymphocyte NAK activity, suggesting 
that this parameter might be a biomarker of autism. Future work should be addressed at 
understanding how sensitive and specific is the decrease of NKA as far as autism is concerned. A 
number of other factors may affect NKA; for example, a positive correlation between the 
molecular activity of Na+/K+-ATPase units and the membrane content of DHA has been shown 
[Turner N et al., 2003] and a reduction of NKA has also been related to oxidative stress [Rodrigo R 
et al., 2007], [Vignini A et al. 2009]. Changes in ATPase activities might stem from sub-
conformational changes in the enzymes depending on their microenvironment, indirectly 
reflecting changes in surrounding lipids and in membrane fluidity [Kamboj SS, et al. 2009]. In 
summary, although the study awaits to be completed with new antibodies and a quantitative 
decrease of one or more protein subunits has not yet ruled out, two hypotheses are in our opinion 
the most likely: either the functional alteration of the enzyme due to the oxidation of one or more 
subunits or the presence of plasmatic inhibitors, such as metals and/or endogenous ouabain. 
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Noteworthy, some clinical features were correlated with some parameters of the lipidomic 
profile. In our study, hyperactivity is the clinical aspect found to be most highly related to 
erythrocyte membrane features. The higher the fluidity of the erythrocyte membrane and the 
lower the PUFA concentration, the greater was the hyperactivity level. Also, the severity of 
hyperactivity was directly and highly correlated with erythrocyte SFA and palmitic acid 
concentration. These data not only suggest that such disequilibrium in membrane fatty acid 
composition may be a useful tool to assess the severity of the autistic clinical picture, but also 
suggest possible therapeutic interventions with a tailored and balanced fatty acid intake. Two 
distinct double blind trials showed an improvement in hyperactivity score in autistic children 
treated with ω3 supplementation [Amminger GP, et al., 2007; Bent S et al., 2011]. Despite these 
encouraging results, a Cochrane meta-analysis stated that “to date there is no high quality 
evidence that omega-3 fatty acids supplementation is effective for improving core and associated 
symptoms of ASD” [James S et al., 2011]. Nevertheless, our data clearly show an imbalance of 
membrane fatty acids and their correlation with relevant clinical features, thus pointing to the 
importance of restoring the membrane equilibrium. However, the intake of ω3 should be 
accompanied by antioxidant protection. For example, since our data also show the alteration of 
the redox balance of Au, supplementation of PUFA in the absence of antioxidant protection might 
paradoxically worsen the picture, as, in oxidative milieu, PUFA undergo a peroxidation process and 
may become, in turn, pro-oxidant. Also, omega-6/omega-3 balance might modulate 
neurotransmitters of the central nervous system: increased omega-3 fatty acid concentrations in 
cell membranes have been shown to affect serotonin and dopamine neurotransmission, especially 
in the prefrontal cortex [Chalon S (2006)]. Taking into account that serotoninergic and 
dopaminergic systems are deeply involved in ASD [Pardo CA, Eberhart CG (2007)], [Farook MF et 
al. 2012], cell membrane lipid profile restoration could play a significant therapeutic role in 
improving some ASD features. In Au children, levels of Peroxiredoxin I (that are not statistically  
different in comparison to those of TD group) seems inversely related  to the severity of clinical 
features: the hypothesis is that a lower availability of endogenous antioxidant protection may 
promote the oxidative stress in conditions of alterated oxidative balance, resulting in cellular 
damage. 
Through a convention with the University of Warwick, the analysis of glycation and of 
nitrosylation of plasma and urine proteins has been carried out.  Although the analyses have been 
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completed, data are still being elaborated. These evaluations have never been carried out in 
autistic subjects.  
Since a number of trace elements may affect several enzyme functions, when present in 
concentration above the normal range, we also sent aliquots of plasma and urine to the Istituto 
Zoo-profilattico della Lombardia e dell’Emilia Romagna (IZSLER) in order to obtain the 
quantitative analysis of the following metals: As, Bi, Ca, Cd, Cr, Cu, Fe, Mg, K, Mg, Mn, Ni, Pb, Se, 
Na, Sb, Sn, Tl, Cs, V, Li, Zn, U, Al, Hg. In particular, our attention has been attracted by the fact that 
the Vanadium salt orthovanadate is both an inhibitor of NKA and of Band 3 dephosphorylation. 
Therefore, should the quantitative analysis of trace elements reveal a significant increase of 
Vanadium, a link between morphological alterations of erythrocytes, NKA activity reduction and 
oxidative stress would be provided. 
We are planning to study the transmembrane protein Band 3, a highly expressed anion exchanger, 
which plays a crucial role in cytoskeletal organization. When modified by oxidation, it is 
extensively phosphorylated by Lyn and Syk Tyr-kinases. This causes it to release cytoskeletal 
components and favors its clustering and its release within microvescicles (Ferru E et al., 2011).  
The figures below summarize the main hypotheses emerged in our study 
3.5 Conclusions and future perspective 
In summary, our results support the notion that a systemic oxidative stress is present in AU 
patients, that alterations in functional, structural and morphological features of erythrocyte may 
play a role in the pathogenesis of Autism, that some of the parameter we have studied (such as 
erythrocyte and lymphocyte Na+ K+ ATPase activity) are strongly candidates for peripheral 
biomarkers of ASD, to be exploited for a more precise or an earlier diagnosis of ASD.    
Our research has now many future directions: a) to collect the latest data that we lack on possible 
environmental factors (pollutants, metals), b) to understand the reason(s) for the impairment of 
the NKA, c) to deepen the study of the components of the red cell membrane and cytoskeleton, d) 
to test the sensitivity and specificity of altered biochemical parameters in order to use them as 
peripheral biomarkers, e) to identify an evidence-based pharmacological/nutraceutical 
intervention in the light of what has emerged from this study. 
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Supplementary material 
Table 1S Erythrocyte membrane features and molecules, oxidative stress markers in urine and plasma, oxidative 
stress-related markers in erythrocytes, First study  (form Ghezzo A et al. 2013) 
 Mean values (± St. Dev) p (p calculated) P (FDR) 
 Au  (N=21) TD (N=20)   
Erythrocyte membrane features and molecules  
Na+/K+ATPasi µgPi/mg prt/h* 2.54 (± 0.58) 7.39 (± 1.62) <.0001  (<0.0001) <.0001 
TMA-DPH* 0.27 (± 0.02) 0.25 (± 0.03) <0.05  (0.0123)  0.0368 
DPH* 0.27 (± 0.02) 0.25 (± 0.03) <0.05     (0.0196)  0.0469 
TBARS* 0.72 (± 0.38) 0.51 (± 0.37) <0.01 (0.0021) 0.0125 
Sialic Acid* 6.19 (±4.36) 7.63 (±7.08) NS         (0.7248) 0.7248 
  
Oxidative stress markers in urine  
Isoprostane ng/mg creat.* 3.04 (±1.50) 2.07 (±0.54) <0.01 (0.0069) 0.0278 
Hexanoyl-lysine adduct° 0.16 (±0.09) 0.11 (±0.05)  <0.05    (0.0380) 0.0760 
8-Oxo-guanosine°  484.80  (±130.07) 426.46 (±163.64) NS         (0.2127) 0.365 
     
Oxidative stress markers in plasma  
Carbonyl Groups° 0.30 (±0.08) 0.27 (±0.11) NS         (0.2509) 0.3763 
Radical Absorbance Capacity* 2.47 (±0.86) 2.36 (±0.94) NS         (0.4573) 0.5487 
     
Oxidative stress-related markers 
in erythrocytes 
 
SOD activity*          (Au N=12) 26.10 (±4.02)  25.49 (±3.78) NS          (0.2960) 0.3947 
Catalase activity°    (Au N=12) 29.28 (±6.34)  31.25 (±11.06) NS          (0.5783) 0.6309 
*Non parametric Wicoxon-Mann-Whithey test applied 
° Parametric ANOVA test applied 
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Table 2S Erythrocyte membrane Fatty Acid profile (From Ghezzo A. et al. 2013) 
 
Test AD (n: 21) TD (n: 20) P False Discovery Rate  
 Means values  ± SD  Means values  ± SD  p-value  
DHA omega 3 (22:6)*  4.8 ± 1.08   5.61 ± 0.67 0.0065 0.07220  
Total Monounsaturated Fatty Acid 
(MUFA)* 18.03 ± 1.25 17.03 ± 0.98 0.0076 0.07220  
Vaccenic acid (18:1)°   1.3 ± 0.16   1.19 ± 0.11 0.0220 0.08297  
Oleic acid (18:1)* 16.42 ± 1.25 15.6 ± 0.94 0.0228 0.08297  
SFA / MUFA°   2.38 ± 0.24   2.5 ± 0.19 0.0232 0.08297  
Palmitoleic acid (16:1)°   0.3 ± 0.08   0.24 ± 0.09 0.0262 0.08297  
EPA omega 3 (20:5)°   0.43 ± 0.15   0.51 ± 0.14 0.0434 0.11780  
omega6 /omega3°   6.66 ± 1.62   5.76 ± 0.67 0.0600 0.14250  
Total  Polyunsaturated  Fatty (PUFA)° 39.39 ± 1.8 40.18 ± 1.74 0.1173 0.24763  
Trans 18:1°   0.11 ± 0.05   0.14  ± 0.07 0.1863 0.35397  
Stearic acid (18:0)* 18.58 ± 1.04 18.78 ± 0.88 0.2709 0.46792  
Eicosatrienoic acid omega 6 (20:3)°   2.25 ± 0.45   2.13 ± 0.34 0.3714 0.58805  
Total  Saturated Fatty Acid (SFA)*   0.66 ± 0.07   0.67± 0.08 0.6012 0.76738  
Linoleic omega 6 (18:2)°   0.23 ±  0.08   0.23  ± 0.06 0.6012 0.76738  
Total TRANS°   0.12 ± 0.06   0.11  ± 0.03 0.6180 0.76738  
Trans-ARA° 42.31 ± 1.96 42.6 ± 1.53 0.6756 0.76738  
Arachidonic acid  omega 6 (20:4)* 19.57 ± 1.67 19.38 ± 1.13 0.6866 0.76738  
EFA deficiency° 23.73 ± 1.94 23.81 ± 1.48 0.7961 0.84033  
Palmitic acid (16:0)* 12.2 ± 0.96 12.66 ±  1.34 0.8810 0.88100  
 
° Wilcoxon – Mann - Whitney test 
*t Student test 
